Norwood Financial (NWFL) 10-Q 8 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 01, 2020
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Current Fiscal Year End Date	--12-31
Entity Registrant Name	NORWOOD FINANCIAL CORP
Entity Central Index Key	0001013272
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		6,328,790

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and due from banks	$ 14,712	$ 15,038
Interest-bearing deposits with banks	23,706	377
Cash and cash equivalents	38,418	15,415
Securities available for sale, at fair value	196,998	210,205
Loans receivable	928,565	924,581
Less: Allowance for loan losses	9,088	8,509
Net loans receivable	919,477	916,072
Regulatory stock, at cost	3,770	4,844
Bank premises and equipment, net	14,071	14,228
Bank owned life insurance	38,971	38,763
Accrued interest receivable	3,669	3,719
Foreclosed real estate owned	1,077	1,556
Goodwill	11,331	11,331
Other intangibles	212	235
Other assets	14,297	14,242
Total Assets	1,242,291	1,230,610
LIABILITIES
Deposits: Noninterest-bearing	213,359	207,299
Deposits: Interest-bearing	776,801	750,230
Total deposits	990,160	957,529
Short-term borrowings	40,656	62,256
Other borrowings	51,350	56,438
Accrued interest payable	2,895	2,432
Other liabilities	15,043	14,527
TOTAL LIABILITIES	1,100,104	1,093,182
STOCKHOLDERS' EQUITY
Preferred stock, no par value per share, authorized: 5,000,000 shares; issued: none
Common stock, $0.10 par value per share, authorized: 20,000,000 shares, issued: 2020: 6,342,568 shares, 2018: 6,340,563 shares	634	634
Surplus	49,644	49,471
Retained earnings	88,032	86,536
Treasury stock at cost: 2020 and 2019: 12,007 shares	(400)	(400)
Accumulated other comprehensive income	4,277	1,187
TOTAL STOCKHOLDERS' EQUITY	142,187	137,428
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,242,291	$ 1,230,610

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Consolidated Balance Sheets [Abstract]
Preferred Stock, No Par Value
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Common Stock, Par Value Per Share	$ 0.10	$ 0.10
Common Stock, Shares Authorized	20,000,000	20,000,000
Common Stock, Shares, Issued	6,342,568	6,340,563
Treasury Stock, Shares	12,007	12,007

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
INTEREST INCOME
Loans receivable, including fees	$ 10,683	$ 9,970
Securities	1,179	1,441
Other	6	15
Total interest income	11,868	11,426
INTEREST EXPENSE
Deposits	1,790	1,729
Short-term borrowings	111	123
Other borrowings	302	303
Total interest expense	2,203	2,155
NET INTEREST INCOME	9,665	9,271
PROVISION FOR LOAN LOSSES	700	450
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES	8,965	8,821
OTHER INCOME
Other Income	1,331	1,301
Net realized gains on sales of securities	38	0
Gain on sale of loans, net	56	42
Earnings and proceeds on bank owned life insurance	208	202
Other	136	143
Total other income	1,654	1,560
OTHER EXPENSES
Salaries and employee benefits	3,777	3,649
Occupancy, furniture & equipment, net	968	924
Data processing and related operations	437	448
Taxes, other than income	214	161
Professional fees	218	250
Federal Deposit Insurance Corporation insurance	0	71
Foreclosed real estate	16	23
Amortization of intangibles	23	29
Other	1,406	1,093
Total Other Expenses	7,059	6,648
INCOME BEFORE INCOME TAXES	3,560	3,733
INCOME TAX EXPENSE	481	543
NET INCOME	$ 3,079	$ 3,190
BASIC EARNINGS PER SHARE	$ 0.49	$ 0.51
DILUTED EARNINGS PER SHARE	$ 0.49	$ 0.51
Service Charges And Fees [Member]
OTHER INCOME
Other Income	$ 1,063	$ 1,031
Income From Fiduciary Activities [Member]
OTHER INCOME
Other Income	$ 153	$ 142

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 3,079	$ 3,190
Investment securities available for sale:
Unrealized holding gain	3,949	3,725
Tax effect	(829)	(782)
Reclassification of investment securities gains recognized in net income	(38)	0
Tax effect	8	0
Other comprehensive income	3,090	2,943
Comprehensive Income	$ 6,169	$ 6,133

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Surplus [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning balance at Dec. 31, 2018	$ 630	$ 48,322	$ 78,434	$ (81)	$ (5,020)	$ 122,285
Beginning balance, shares at Dec. 31, 2018	6,295,113			2,470
Net income			3,190			3,190
Other comprehensive income (loss)					2,943	2,943
Cash dividends declared			(1,509)			(1,509)
Compensation expense related to restricted stock		72				72
Acquisition of treasury stock				$ (374)		(374)
Acquisition of treasury stock, shares				11,337
Stock options exercised		113				113
Stock options exercised, shares	6,150
Compensation expense related to stock options		52				52
Ending balance, shares at Mar. 31, 2019	6,301,263			13,807
Ending balance at Mar. 31, 2019	$ 630	48,559	80,115	$ (455)	(2,077)	126,772
Beginning balance at Dec. 31, 2019	$ 634	49,471	86,536	$ (400)	1,187	137,428
Beginning balance, shares at Dec. 31, 2019	6,340,563			12,007
Net income			3,079			3,079
Other comprehensive income (loss)					3,090	3,090
Cash dividends declared			(1,583)			(1,583)
Compensation expense related to restricted stock		84				84
Stock options exercised		38				$ 38
Stock options exercised, shares	2,005					2,005
Compensation expense related to stock options		51				$ 51
Ending balance, shares at Mar. 31, 2020	6,342,568			12,007
Ending balance at Mar. 31, 2020	$ 634	$ 49,644	$ 88,032	$ (400)	$ 4,277	$ 142,187

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Consolidated Statements of Changes in Stockholders' Equity [Abstract]
Cash dividends declared	$ 0.25	$ 0.24

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 3,079	$ 3,190
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	700	450
Depreciation	281	241
Amortization of intangible assets	23	29
Deferred income taxes	(250)	(40)
Net amortization of securities premiums and discounts	320	371
Net realized gains on sales of securities	(38)	0
Earnings and proceeds on life insurance policies	(208)	(202)
Gain on sales and write-downs of fixed assets and foreclosed real estate owned, net	(3)	(8)
Net gain on sale of loans	(56)	(42)
Loans originated for sale	(1,535)	(732)
Proceeds from sale of loans originated for sale	1,545	758
Compensation expense related to stock options	51	52
Compensation expense related to restricted stock	84	72
Decrease (increase) in accrued interest receivable	50	(313)
Increase in accrued interest payable	463	651
Other, net	38	(201)
Net cash provided by operating activities	4,544	4,276
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sales	8,224	327
Proceeds from maturities and principal reductions on mortgage-backed securities	15,646	5,684
Purchases	(7,034)	0
Purchase of regulatory stock	(1,305)	(1,112)
Redemption of regulatory stock	2,379	1,906
Net increase in loans	(4,208)	(15,352)
Purchase of premises and equipment	(124)	(560)
Proceeds from sales of foreclosed real estate owned	482	44
Net cash provided by (used in) investing activities	14,060	(9,063)
CASH FLOWS FROM FINANCING ACTIVITIES
Net increase in deposits	32,631	27,635
Net increase in short-term borrowings	(21,600)	(15,222)
Repayments of other borrowings	(5,088)	(4,329)
Stock options exercised	38	113
Purchase of treasury stock	0	(374)
Cash dividends paid	(1,582)	(1,510)
Net cash provided by financing activities	4,399	6,313
Increase in cash and cash equivalents	23,003	1,526
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	15,415	18,348
CASH AND CASH EQUIVALENTS, END OF PERIOD	38,418	19,874
Supplemental Disclosures of Cash Flow Information
Interest on deposits and borrowings	1,740	1,504
Income taxes paid, net of refunds	53	46
Supplemental Schedule of Noncash Investing Activities
Transfers of loans to foreclosed real estate owned and repossession of other assets	99	822
Dividends payable	1,583	1,509
Right of use for operating leases	0	5,335
Lease liability for operating leases	$ 0	$ 5,335

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The unaudited consolidated financial statements include the accounts of Norwood Financial Corp. (Company) and its wholly-owned subsidiary, Wayne Bank (Bank) and the Bank’s wholly-owned subsidiaries, WCB Realty Corp., Norwood Investment Corp., and WTRO Properties, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.  The accompanying unaudited consolidated financial statements have been prepared in conformity with generally accepted accounting principles for interim financial statements and with instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and revenues and expenses for the period. Actual results could differ from those estimates. The financial statements reflect, in the opinion of management, all normal, recurring adjustments necessary to present fairly the consolidated financial position and results of operations of the Company. The operating results for the three month period ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020 or any other future interim period. 

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2020
Revenue Recognition [Abstract]
Revenue Recognition	2 . Revenue Recognition  Under ASC Topic 606, management determined that the primary sources of revenue emanating from interest and dividend income on loans and investments along with noninterest revenue resulting from investment security gains, loan servicing, gains on the sale of loans sold and earnings on bank-owned life insurance are not within the scope of this Topic.  The following presents noninterest income, segregated by revenue streams in-scope and out-of-scope of Topic 606, for the three months ended March 31:    Three months ended  March 31,   (dollars in thousands)   Noninterest Income 2020 2019  In-scope of Topic 606:  Service charges on deposit accounts $ 96 $ 67  ATM fees 95 90  Overdraft fees 344 351  Safe deposit box rental 29 26  Loan related service fees 100 129  Debit card fees 344 326  Fiduciary activities 153 142  Commissions on mutual funds and annuities 38 55  Other income 132 115  Noninterest Income ( in-scope of Topic 606 ) 1,331 1,301   Out-of-scope of Topic 606:  Net realized gains on sales of securities 38 -  Loan servicing fees 21 15  Gains on sales of loans 56 42  Earnings on and proceeds from bank-owned life insurance 208 202  Noninterest Income ( out-of-scope of Topic 606 ) 323 259  Total Noninterest Income $ 1,654 $ 1,560    

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	3. Earnings Per Share Basic earnings per share represents income available to common stockholders divided by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect additional common shares that would have been outstanding if dilutive potential common shares had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential common shares that may be issued by the Company relate solely to outstanding stock options and restricted stock, and are determined using the treasury stock method.  The following table sets forth the weighted average shares outstanding used in the computations of basic and diluted earnings per share.       (in thousands) Three Months Ended  March 31,  2020 2019  Weighted average shares outstanding 6,330 6,293  Less: Unvested restricted shares (36) (34)  Basic EPS weighted average shares outstanding 6,294 6,259    Basic EPS weighted average shares outstanding 6,294 6,259  Add: Dilutive effect of stock options and restricted shares 29 50  Diluted EPS weighted average shares outstanding 6,323 6,309  For the three month period ended March 31, 2 0 20 , there were 82,600 stock options that w ere anti-dilutive and thereby excluded from the earnings per share calculations based upon the closing price of Norwood common stock of $26.70 per share as of March 31, 2020.   As of March 31, 2019, there were 60,650 stock options that would be anti-dilutive to the earnings per share calculations based upon the closing price of Norwood common stock of $30.84 per share on March 31, 2019.

Stock Based Compensation

Stock Based Compensation	3 Months Ended
	Mar. 31, 2020
Stock Based Compensation [Abstract]
Stock Based Compensation	4. Stock-Based Compensation  No awards were granted during the three-month period ended March 31, 2020. As of March 31, 2020, there was $153,000 of total unrecognized compensation cost related to non-vested options granted in 2019 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2020. Compensation costs related to stock options amounted to $51,000 and $52,000 during the three-month periods ended March 31, 2020 and 2019, respectively.  A summary of the Company’s stock option activity for the three-month period ended March 31, 2020 is as follows:     Weighted  Average Exercise Weighted Average Aggregate  Price Remaining Intrinsic Value  Options Per Share Contractual Term ($000)   Outstanding at January 1, 2020 199,825 $ 24.78 5.9 Yrs. $ 2,822  Granted - - - -  Exercised (2,005) 19.25 5.8 Yrs. 33  Forfeited - - -  Outstanding at March 31, 2020 197,820 $ 24.83 5.7 Yrs. $ 370   Exercisable at March 31, 2020 171,070 $ 23.08 5.0 Yrs. $ 620  Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $26.70 per share as of March 31, 2020 and $38.90 per share as of December 31, 2019.  A summary of the Company’s restricted stock activity for the three-month periods ended March 31, 2020 and 2019 is as follows:     2020 2019  Weighted-Average Weighted-Average  Number of Grant Date Number of Grant Date  Restricted Stock Fair Value Restricted Stock Fair Value  Non-vested, January 1, 36,195 $ 36.23 34,615 $ 27.82  Granted - - - -  Vested - - - -  Forfeited - - - -  Non-vested, March 30, 36,195 $ 36.23 34,615 $ 27.82    The expected future c ompensation expense relating to the 36,195 shares of non-vested restrict ed stock outstanding as of March 3 1 , 20 20 is $1,062,000 . This cost will be recognized over the remaining vesting period of 4.75 years. Compensation costs related to restricted stock amounted to $84,000 and $72,000 during the three-month periods ended March 31, 2020 and 2019, respectively.  

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Abstract]
Accumulated Other Comprehensive Income (Loss)	5. Accumulated Other Comprehensive Income (Loss)  The following table presents the changes in accumulated other comprehensive income (loss) (in thousands) by component net of tax for the three months ended March 31, 2020 and 2019:        Unrealized gains (losses) on  available for sale  securities (a)  Balance as of December 31, 2019 $ 1,187  Other comprehensive income before reclassification 3,120  Amount reclassified from accumulated other comprehensive income (30)  Total other comprehensive income 3,090  Balance as of March 31, 2020 $ 4,277    Unrealized gains (losses) on  available for sale  securities (a)  Balance as of December 31, 2018 $ (5,020)  Other comprehensive loss before reclassification 2,943  Amount reclassified from accumulated other comprehensive loss -  Total other comprehensive loss 2,943  Balance as of March 31, 2019 $ (2,077)                (a) All amounts are net of tax. Amounts in parentheses indicate debits. The following table presents significant amounts reclassified out of each component of accumulated other comprehensive income (loss) (in thousands) for the three months ended March 31, 2020 and 2019:              Amount Reclassified  From Accumulated Affected Line Item in  Other Consolidated  Comprehensive Statements  Details about other comprehensive income Income (Loss) (a) of Income   Three months ended  March 31,  2020 2019  Unrealized gains on available for sale securities $ 38 $ - Net realized gains on sales of securities  (8) - Income tax expense  $ 30 $ -   (a) Amounts in parentheses indicate debits to net income 

Off-Balance Sheet Financial Ins

Off-Balance Sheet Financial Instruments and Guarantees	3 Months Ended
	Mar. 31, 2020
Off-Balance Sheet Financial Instruments and Guarantees [Abstract]
Off-Balance Sheet Financial Instruments and Guarantees	6. Off-Balance Sheet Financial Instruments and Guarantees  The Bank is a party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the balance sheets.  The Bank’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and letters of credit is represented by the contractual amount of those instruments. The Bank uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments.  A summary of the Bank’s financial instrument commitments is as follows:       (in thousands) March 31,  2020 2019   Commitments to grant loans $ 55,036 $ 40,322  Unfunded commitments under lines of credit 68,530 77,573  Standby letters of credit 4,065 4,183  $ 127,631 $ 122,078  Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since some of the commitments are expected to expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Bank evaluates each customer’s credit worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Bank upon extension of credit, is based on management’s credit evaluation of the customer and generally consists of real estate.  The Bank does not issue any guarantees that would require liability recognition or disclosure, other than its standby letters of credit. Standby letters of credit written are conditional commitments issued by the Bank to guarantee the performance of a customer to a third party. Generally, all letters of credit, when issued, have expiration dates within one year. The credit risk involved in issuing letters of credit is essentially the same as those that are involved in extending loan facilities to customers. The Bank, generally, holds collateral and/or personal guarantees supporting these commitments. Management believes that the proceeds obtained through a liquidation of collateral and the enforcement of guarantees would be sufficient to cover the potential amount of future payments required under the corresponding guarantees. The current amount of the liability as of March 31, 2020 for guarantees under standby letters of credit issued is not material.

Securities

Securities	3 Months Ended
	Mar. 31, 2020
Securities [Abstract]
Securities	7. Securities  The amortized cost, gross unrealized gains and losses, and fair value of securities available for sale were as follows:     March 31, 2020  Gross Gross  Amortized Unrealized Unrealized Fair  Cost Gains Losses Value  (In Thousands)  Available for Sale:  States and political subdivisions $ 58,182 $ 1,340 $ (1) $ 59,521  Corporate obligations 3,076 - (11) 3,065  Mortgage-backed securities-  government sponsored entities 131,382 3,030 - 134,412  Total debt securities $ 192,640 $ 4,370 $ (12) $ 196,998      December 31, 2019  Gross Gross  Amortized Unrealized Unrealized Fair  Cost Gains Losses Value   (In Thousands)  Available for Sale:  States and political subdivisions $ 70,015 $ 1,293 $ (3) $ 71,305  Corporate obligations 4,097 3 - 4,100  Mortgage-backed securities-government  sponsored entities 135,646 238 (1,084) 134,800  Total debt securities $ 209,758 $ 1,534 $ (1,087) $ 210,205     The following tables show the Company’s investments’ gross unrealized losses and fair value aggregated by length of time that individual securities have been in a continuous unrealized loss position (in thousands):     March 31, 2019  Less than 12 Months 12 Months or More Total  Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses  States and political subdivisions $ 1,195 $ (1) $ - $ - $ 1,195 $ (1)  Corporate obligations 3,065 (11) - - 3,065 (11)  $ 4,260 $ (12) $ - $ - $ 4,260 $ (12)      December 31, 2019  Less than 12 Months 12 Months or More Total  Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses  States and political subdivisions $ 1,296 $ (2) $ 481 $ (1) $ 1,777 $ (3)  Mortgage-backed securities-government sponsored entities 32,415 (241) 61,096 (843) 93,511 (1,084)  $ 33,711 $ (243) $ 61,577 $ (844) $ 95,288 $ (1,087)  At March 31, 2020, the Company had five debt s ecurities in an unrealized loss position in the less than twelve months category and no debt securities in the twelve months or more category. In Management’s opinion the unrealized losses reflect changes in interest rates subsequent to the acquisition of specific securities. No other-than-temporary-impairment charges were recorded in 2020. Management believes that all unrealized losses represent temporary impairment of the securities as the Company does not have the intent to sell the securities and it is more likely than not that it will not have to sell the securities before recovery of its cost basis.  The amortized cost and fair value of debt securities as of March 31, 2020 by contractual maturity are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to prepay obligations with or without call or prepayment penalties.      Available for Sale  Amortized Cost Fair Value  (In Thousands)   Due in one year or less $ 2,742 $ 2,747  Due after one year through five years 10,370 10,377  Due after five years through ten years 20,876 21,091  Due after ten years 27,270 28,371  61,258 62,586  Mortgage-backed securities-government sponsored entities 131,382 134,412  $ 192,640 $ 196,998        Gross realized gains and gross realized losses on sales of securities available for sale were as follows (in thousands):      Three Months  Ended March 31,  2020 2019  Gross realized gains $ 38 $ -  Gross realized losses - -  Net realized gain $ 38 $ -  Proceeds from sales of securities $ 8,224 $ 327            Securities with a carrying value of $177,342,000 and $196,137,000 at March 31, 2020 and 2019, respectively, were pledged to secure public deposits, securities sold under agreements to repurchase and for other purposes as required or permitted by law.

Loans Receivable and Allowance

Loans Receivable and Allowance for Loan Losses	3 Months Ended
	Mar. 31, 2020
Loans Receivable and Allowance for Loan Losses [Abstract]
Loans Receivable and Allowance for Loan Losses	8. Loans Receivable and Allowance for Loan Losses Set forth below is selected data relating to the composition of the loan portfolio at the dates indicated (dollars in thousands):         March 31, 2020 December 31, 2019  Real Estate Loans:  Residential $ 227,373 24.5 % $ 229,781 24.9 %  Commercial 398,492 42.9 391,327 42.3  Construction 16,622 1.8 17,732 1.9  Commercial, financial and agricultural 132,716 14.3 134,150 14.5  Consumer loans to individuals 153,394 16.5 151,686 16.4  Total loans 928,597 100.0 % 924,676 100.0 %  Deferred fees, net (32) (95)  Total loans receivable 928,565 924,581  Allowance for loan losses (9,088) (8,509)  Net loans receivable $ 919,477 $ 916,072   The following table presents information regarding loans acquired and accounted for in accordance with ASC 310-30 (in thousands):      March 31, 2020 December 31, 2019   Outstanding Balance $ 777 $ 793  Carrying Amount $ 680 $ 696    As a result of the acquisition of Delaware Bancshares, Inc. (“Delaware”), the Company added $1,397,000 of loans that were accounted for in accordance with ASC 310-30. Based on a review of the loans acquired by senior lending management, which included an analysis of credit deterioration of the loans since origination, the Company recorded a specific credit fair value adjustment of $499,000 . For loans that were acquired with specific evidence of deterioration in credit quality, loan losses will be accounted for through a reduction of the specific reserve and will not impact the allowance for loan losses until actual losses exceed the allotted reserves. For loans acquired without a deterioration of credit quality, losses incurred will result in adjustments to the allowance for loan losses through the allowance for loan loss adequacy calculation.  The Company maintains a loan review system, which allows for a periodic review of our loan portfolio and the early identification of potential impaired loans. Such system takes into consideration, among other things, delinquency status, size of loans, type and market value of collateral and financial condition of the borrowers. Specific loan loss allowances are established for identified losses based on a review of such information. A loan evaluated for impairment is considered to be impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. All loans identified as impaired are evaluated independently. We do not aggregate such loans for evaluation purposes. Impairment is measured on a loan-by-loan basis for commercial and construction loans by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral-dependent.  Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, the Company does not separately identify individual consumer and residential mortgage loans for impairment disclosures, unless such loans are part of a larger relationship that is impaired, or are classified as a troubled debt restructuring.  Foreclosed assets acquired in settlement of loans are carried at fair value less estimated costs to sell and are included in foreclosed real estate owned on the Consolidated Balance Sheets. As of March 31, 2020 and December 31, 2019, foreclosed real estate owned totaled $1,077,000 and $1,556,000, respectively. During the three months ended March 3 1 , 20 20 , there were no additions to the foreclosed real estate category . The Co mpany partially disposed of one propert y that w as previously transferred to foreclosed real estate owned with a carrying value of $479,000 through the sale of the propert y . The remaining proceeds from the sale of this property are being held in escrow pending final disposition. As of March 3 1 , 20 20 , the Company has initiated formal foreclosure proceedings on three properties classified as consumer residential mortgages with an aggregate carrying value of $296,000 .  The following table shows the amount of loans in each category that were individually and collectively evaluated for impairment at the dates indicated:      Real Estate Loans  Commercial Consumer  Residential Commercial Construction Loans Loans Total  March 31, 2020 (In thousands)   Individually evaluated for impairment $ - $ 2,096 $ - $ - $ - $ 2,096  Loans acquired with deteriorated credit quality 467 213 - - - 680  Collectively evaluated for impairment 226,906 396,183 16,622 132,716 153,394 925,821  Total Loans $ 227,373 $ 398,492 $ 16,622 $ 132,716 $ 153,394 $ 928,597      Real Estate Loans  Commercial Consumer  Residential Commercial Construction Loans Loans Total  (In thousands)  December 31, 2019   Individually evaluated for impairment $ - $ 2,144 $ - $ - $ - $ 2,144  Loans acquired with deteriorated credit quality 476 220 - - - 696  Collectively evaluated for impairment 229,305 388,963 17,732 134,150 151,686 921,836  Total Loans $ 229,781 $ 391,327 $ 17,732 $ 134,150 $ 151,686 $ 924,676  The following table includes the recorded investment and unpaid principal balances for impaired loans with the associated allowance amount, if applicable.     Unpaid  Recorded Principal Associated  Investment Balance Allowance  March 31, 2020 (in thousands)  With no related allowance recorded:  Real Estate Loans:  Commercial $ 173 $ 173 $ -  Subtotal 173 173 -   With an allowance recorded:  Real Estate Loans  Commercial 1,923 1,923 392  Subtotal 1,923 1,923 392   Total:  Real Estate Loans:  Commercial 2,096 2,096 392  Total Impaired Loans $ 2,096 $ 2,096 $ 392      Unpaid  Recorded Principal Associated  Investment Balance Allowance  December 31, 2019 (in thousands)  With no related allowance recorded:  Real Estate Loans:  Commercial $ 143 $ 394 $ -  Subtotal 143 394 -   With an allowance recorded:  Real Estate Loans  Commercial 2,001 2,001 417  Subtotal 2,001 2,001 417  Total:  Real Estate Loans:  Commercial 2,144 2,395 417  Total Impaired Loans $ 2,144 $ 2,395 $ 417  The following table presents the average recorded investment in impaired loans and the related amount of interest income recognized during the three-month periods ended March 31, 2020 and 2019, respectively (in thousands):       Average Recorded Interest Income  Investment Recognized  2020 2019 2020 2019   Real Estate Loans:  Commercial 2,098 885 3 -  Total $ 2,098 $ 885 $ 3 $ -      Troubled debt restructured loans are those loans whose terms have been renegotiated to provide a reduction or deferral of principal or interest as a result of financial difficulties experienced by the borrower, who could not obtain comparable terms from alternate financing sources. As of March 31, 2020 and December 31, 2019, troubled debt restructured loans totaled $96,000 and $ 99,000 , respectively , with no specific reserve. For the three-month period ended March 31, 2020 and 2019, there were no new loans identified as troubled debt restructurings nor did the Company recognized any charge-off on a loan that was previously identified as a troubled debt restructuring.  Management uses an eight point internal risk rating system to monitor the credit quality of the overall loan portfolio. The first four categories are considered not criticized, and are aggregated as “Pass” rated. The criticized rating categories utilized by management generally follow bank regulatory definitions. The Special Mention category includes assets that are currently protected but are potentially weak, resulting in an undue and unwarranted credit risk, but not to the point of justifying a Substandard classification. Loans in the Substandard category have well-defined weaknesses that jeopardize the liquidation of the debt, and have a distinct possibility that some loss will be sustained if the weaknesses are not corrected. All loans greater than 90 days past due are considered Substandard. Any portion of a loan that has been charged off is placed in the Loss category.  On April 7, 2020, federal banking regulators issued a revised interagency statement that included guidance on their approach for the accounting of loan modifications in light of the economic impact of the COVID-19 pandemic. The guidance interprets current accounting standards and indicates that a lender can conclude that a borrower is not experiencing financial difficulty if short-term modifications are made in response to COVID-19, such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant related to the loans in which the borrower is less than 30 days past due on its contractual payments at the time a modification program is implemented. The agencies confirmed in working with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs.  To help ensure that risk ratings are accurate and reflect the present and future capacity of borrowers to repay a loan as agreed, the Bank has a structured loan rating process with several layers of internal and external oversight. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as nonperformance, repossession, or death occurs to raise awareness of a possible credit event. The Company’s Loan Review Department is responsible for the timely and accurate risk rating of the loans on an ongoing basis. Every credit which must be approved by Loan Committee or the Board of Directors is assigned a risk rating at time of consideration. Loan Review also annually reviews relationships of $1,500,000 and over to assign or re-affirm risk ratings. Loans in the Substandard categories that are collectively evaluated for impairment are given separate consideration in the determination of the allowance.   The following table presents the classes of the loan portfolio summarized by the aggregate Pass and the criticized categories of Special Mention, Substandard, Doubtful and Loss within the internal risk rating system as of March 31, 2020 and December 31, 2019 (in thousands):      Special Doubtful  Pass Mention Substandard or Loss Total  March 31, 2020  Commercial real estate loans $ 384,948 $ 10,633 $ 2,911 $ - $ 398,492  Commercial loans 132,248 240 228 - 132,716  Total $ 517,196 $ 10,873 $ 3,139 $ - $ 531,208        Special Doubtful  Pass Mention Substandard or Loss Total  December 31, 2019  Commercial real estate loans $ 376,109 $ 12,268 $ 2,950 $ - $ 391,327  Commercial loans 133,695 248 207 - 134,150  Total $ 509,804 $ 12,516 $ 3,157 $ - $ 525,477  For residential real estate loans, construction loans and consumer loans, the Company evaluates credit quality based on the performance of the individual credits. The following table presents the recorded investment in the loan classes based on payment activity as of March 31, 2020 and December 31, 2019 (in thousands):      Performing Nonperforming Total  March 31, 2020  Residential real estate loans $ 226,894 $ 479 $ 227,373  Construction 16,622 - 16,622  Consumer loans 153,226 168 153,394  Total $ 396,742 $ 647 $ 397,389      Performing Nonperforming Total  December 31, 2019  Residential real estate loans $ 229,214 $ 567 $ 229,781  Construction 17,732 - 17,732  Consumer loans 151,607 79 151,686  Total $ 398,553 $ 646 $ 399,199             Management further monitors the performance and credit quality of the loan portfolio by analyzing the age of the portfolio as determined by the length of time a recorded payment is past due. The following table presents the classes of the loan portfolio summarized by the aging categories of performing loans and nonaccrual loans as of March 31, 2020 and December 31, 2019 (in thousands):      Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Total Loans  March 31, 2020  Real Estate loans  Residential $ 225,840 $ 849 $ 205 $ - $ 479 $ 1,533 $ 227,373  Commercial 395,516 784 149 - 2,043 2,976 398,492  Construction 16,622 - - - - - 16,622  Commercial loans 132,623 - 40 - 53 93 132,716  Consumer loans 152,770 342 114 - 168 624 153,394  Total $ 923,371 $ 1,975 $ 508 $ - $ 2,743 $ 5,226 $ 928,597        Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Total Loans  December 31, 2019  Real Estate loans  Residential $ 228,242 $ 727 $ 245 $ - $ 567 $ 1,539 $ 229,781  Commercial 388,117 176 2,935 - 99 3,210 391,327  Construction 17,695 - 37 - - 37 17,732  Commercial loans 134,018 82 - - 50 132 134,150  Consumer loans 151,309 233 65 - 79 377 151,686  Total $ 919,381 $ 1,218 $ 3,282 $ - $ 795 $ 5,295 $ 924,676 Management reviews the loan portfolio on a quarterly basis using a defined, consistently applied process in order to make appropriate and timely adjustments to the allowance for loan losses. When information confirms all or part of specific loans to be uncollectible, these amounts are promptly charged off against the allowance.  As of March 3 1 , 20 20 , the allocation of the allowance pertaining to each major category of loans is higher than the allocation as of December 31, 201 9 . This in crease is due primarily to a n increase in the qualitative factor for economic conditions which worsened as a result of the COVID-19 pandemic. The increase in this factor added $1,742,000 to the allowance for loan losses. This was offset partially by a decrease in the qualitative factor relating to loan growth which decreased by $1,087,000 due to a reduction in loan growth from 8.75% in 2019 to 1.72% in the first quarter of 2020 .  The following table presents the allowance for loan losses by the classes of the loan portfolio:            (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total  Beginning balance, December 31, 2019 $ 1,552 $ 4,687 $ 95 $ 949 $ 1,226 $ 8,509  Charge Offs (1) (33) - - (116) (150)  Recoveries 2 4 - 10 13 29  Provision for loan losses 91 257 (8) 105 255 700  Ending balance, March 31, 2020 $ 1,644 $ 4,915 $ 87 $ 1,064 $ 1,378 $ 9,088  Ending balance individually evaluated for impairment $ - $ 392 $ - $ - $ - $ 392  Ending balance collectively evaluated for impairment $ 1,644 $ 4,523 $ 87 $ 1,064 $ 1,378 $ 8,696            (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total  Beginning balance, December 31, 2018 $ 1,328 $ 5,455 $ 93 $ 712 $ 864 $ 8,452  Charge Offs (65) (469) - (1) (63) (598)  Recoveries 11 10 - 10 14 45  Provision for loan losses 181 (49) 15 90 213 450  Ending balance, March 31, 2019 $ 1,455 $ 4,947 $ 108 $ 811 $ 1,028 $ 8,349  Ending balance individually evaluated for impairment $ - $ - $ - $ - $ - $ -  Ending balance collectively evaluated for impairment $ 1,455 $ 4,947 $ 108 $ 811 $ 1,028 $ 8,349  The Company’s primary business activity as of March 31, 2020 was with customers located in northeastern Pennsylvania and the New York counties of Delaware and Sullivan. Accordingly, the Company has extended credit primarily to commercial entities and individuals in this area whose ability to honor their contracts is influenced by the region’s economy.  As of March 31, 2020, the Company considered its concentration of credit risk to be acceptable. The highest concentrations are in commercial rentals with $88.8 million of loans outstanding, or 9.6% of total loans outstanding, and the hospitality/lodging industry with loans outstanding of $65.3 million, or 7.1% of loans outstanding. During 2020, the Company recognized a charge off of $33,000 on one property in the named concentrations.

Operating Leases

Operating Leases	3 Months Ended
	Mar. 31, 2020
Operating Leases [Abstract]
Operating Leases	9. Operating Leases  T he Company leases seven office locations under operating leases. Several assumptions and judgments were made when applying the requirements of Topic 842 to the Company’s existing lease commitments, including the allocation of consideration in the contracts between lease and nonlease components, determination of the lease term, and determination of the discount rate used in calculating the present value of the lease payments.  The Company has elected to account for the variable nonlease components, such as common area maintenance charges, utilities, real estate taxes, and insurance, separately from the lease component. Such variable nonlease components are reported in net occupanc y expense on the Consolidated Statements of Income when paid. These variable nonlease components were excluded from the calculation of the present value of the remaining lease payments, therefore, they are not included in other assets and other liabilities on the Consolidated Balance Sheets. The lease cost associated with the operating leases for the three-month periods ending March 31, 2020 and 2019, am ounted to $140,000 and $128,000 , respectively.  Certain of the Company’s leases contain options to renew the lease after the initial term. Management considers the Company’s historical pattern of exercising renewal options on leases and the positive performance of the leased locations, when determining whether it is reasonably certain that the leases will be renewed. If management concludes that there is reasonable certainty about the renewal option, it is included in the calculation of the remaining term of each applicable lease. The discount rate utilized in calculating the present value of the remaining lease payments for each lease was the Federal Home Loan Bank of Pittsburgh advance rate corresponding to the remaining maturity of the lease. The following table presents the weighted-average remaining lease term and discount rate for the leases outstanding at December 31, 2019.   Operating  Weighted-average remaining term 12.9  Weighted-average discount rate 3.21%  The following table presents the undiscounted cash flows due related to operating leases as of March 31, 2020 , along with a reconciliation to the discounted amount recorded on the Consolidated Balance Sheets:    Undiscounted cash flows due (in thousands) Operating   2020 $ 401  2021 535  2022 535  2023 535  2024 544  2025 and thereafter 3,879  Total undiscounted cash flows 6,429  Discount on cash flows (1,204)  Total lease liabilities $ 5,225 

Fair Value of Assets and Liabil

Fair Value of Assets and Liabilities	3 Months Ended
	Mar. 31, 2020
Fair Value of Assets and Liabilities [Abstract]
Fair Value of Assets and Liabilities	10. Fair Value of Assets and Liabilities  Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In accordance with fair value accounting guidance, the Company measures, records, and reports various types of assets and liabilities at fair value on either a recurring or non-recurring basis in the Consolidated Financial Statements. Those assets and liabilities are presented in the sections entitled “Assets and Liabilities Required to be Measured and Reported at Fair Value on a Recurring Basis” and “Assets and Liabilities Required to be Measured and Reported at Fair Value on a Non-Recurring Basis”. There are three levels of inputs that may be used to measure fair values:  Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.  Level 2 – Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.  Level 3 – Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.  The methods of determining the fair value of assets and liabilities presented in this note are consistent with our methodologies disclosed in Note 15 of the Company’s 2019 Form 10-K.            Assets and Liabilities Required to be Measured and Reported at Fair Value on a Recurring Basis  For financial assets measured at fair value on a recurring basis, the fair value measurements by level within the fair value hierarchy used at March 31, 2020 and December 31, 2019 are as follows:      Fair Value Measurement Using  Reporting Date    Description Total Level 1 Level 2 Level 3  (In thousands)   March 31, 2020  Available for Sale:  States and political subdivisions $ 59,521 $ - $ 59,521 $ -  Corporate obligations 3,065 - 3,065 -  Mortgage-backed securities-government  sponsored entities 134,412 - 134,412 -  Total $ 196,998 $ - $ 196,998 $ -    Description Total Level 1 Level 2 Level 3  (In thousands)   December 31, 2019  Available for Sale:  States and political subdivisions $ 71,305 $ - $ 71,305 $ -  Corporate obligations 4,100 - 4,100 -  Mortgage-backed securities-government  sponsored entities 134,800 - 134,800 -  Total $ 210,205 $ - $ 210,205 $ -  Securities:  The fair value of securities available for sale (carried at fair value) and held to maturity (carried at amortized cost) are determined by obtaining quoted market prices on nationally recognized securities exchanges (Level 1), or matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices. For certain securities which are not traded in active markets or are subject to transfer restrictions, valuations are adjusted to reflect illiquidity and/or non-transferability, and such adjustments are generally based on available market evidence (Level 3). In the absence of such evidence, management’s best estimate is used. Management’s best estimate consists of both internal and external support on certain Level 3 investments. Internal cash flow models using a present value formula that includes assumptions market participants would use along with indicative exit pricing obtained from broker/dealers (where available) are used to support fair values of certain Level 3 investments, if applicable.         Assets and Liabilities Required to be Measured and Reported at Fair Value on a Non-Recurring Basis  For financial assets measured at fair value on a nonrecurring basis, the fair value measurements by level within the fair value hierarchy used at March 31, 2020 and December 31, 2019 are as follows:     Fair Value Measurement Using Reporting Date   (In thousands)   Description Total Level 1 Level 2 Level 3  March 31, 2020  Impaired Loans $ 1,531 $ - $ - $ 1,531  Foreclosed Real Estate Owned 1,077 - - 1,077    December 31, 2019  Impaired Loans $ 1,584 $ - $ - $ 1,584  Foreclosed Real Estate Owned 1,556 - - 1,556   Impaired loans (generally carried at fair value):  The Company measures impairment generally based on the fair value of the loan’s collateral. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the lowest level of input that is significant to the fair value measurements.  As of March 31, 2020, the fair value investment in impaired loans totaled $1,531,000 which included one loan relationship that required a valuation allowance of $392,000 since the estimated realizable value of the collateral was not sufficient to cover the recorded investment in the loan. As of March 31, 2020, the Company has recognized a charge-off against the allowance for loan losses on this impaired loan in the amount of $33,000 .  As of December 31, 2019, the fair value investment in impaired loans totaled $1,584,000 which included two loans that required a valuation allowance of $417,000 since the estimated realizable value of the collateral or the discounted cash flows were not sufficient to cover the recorded investment in the loans. As of December 31, 2019, the Company had not recognized any charge-offs against the allowance for loan losses on these impaired loans.  Foreclosed real estate owned (carried at fair value):  Real estate properties acquired through loan foreclosures, or by deed in lieu of loan foreclosure are to be sold and are carried at fair value less estimated cost to sell. Fair value is based upon independent market prices, appraised value of the collateral or management’s estimation of the value of the collateral. These assets are included in Level 3 fair value based upon the lowest level of input that is significant to the fair value measurement.      The following table presents additional quantitative information about assets measured at fair value on a non-recurring basis and for which the Company has utilized Level 3 inputs to determine fair value:    Quantitative Information about Level 3 Fair Value Measurements  (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average)  March 31, 2020  Impaired loans $ 1,531 Appraisal of collateral(1) Appraisal adjustments(2) 10.00% ( 10.00% )   Foreclosed real estate owned $ 1,077 Appraisal of collateral(1) Liquidation Expenses(2) 0 -7.00% ( 6.27% )       Quantitative Information about Level 3 Fair Value Measurements  (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average)  December 31, 2019  Impaired loans $ 1,531 Appraisal of collateral(1) Appraisal adjustments(2) 10.00% ( 10.00% )  Impaired loans $ 53 Present value of future cash flows Loan discount rate 4.00 -6.97% ( 5.55% )  Probability of default 0%   Foreclosed real estate owned $ 1,556 Appraisal of collateral(1) Liquidation Expenses(2) 0 -7.00% ( 4.34% )  (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level 3 inputs which are not identifiable, less any associated allowance. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.  Assets and Liabilities Not Required to be Measured or Reported at Fair Value  The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments at March 31, 2020 and December 31, 2019.  Loans receivable (carried at cost): The fair values of loans are estimated using discounted cash flow analyses, using market rates at the balance sheet date that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values.     Mortgage servicing rights (generally carried at cost) The Company utilizes a third party provider to estimate the fair value of certain loan servicing rights. Fair value for the purpose of this measurement is defined as the amount at which the asset could be exchanged in a current transaction between willing parties, other than in a forced liquidation.  Deposit liabilities (carried at cost): The fair values disclosed for demand deposits (e.g., interest and noninterest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.  Other borrowings (carried at cost): Fair values of FHLB advances are estimated using discounted cash flow analysis, based on quoted prices for new FHLB advances with similar credit risk characteristics, terms and remaining maturity. These prices obtained from this active market represent a fair value that is deemed to represent the transfer price if the liability were assumed by a third party.       The estimated fair values of the Bank’s financial instruments not required to be measured or reported at fair value were as follows at March 31, 2020 and December 31, 2019. (In thousands)     Fair Value Measurements at March 31, 2020  Carrying Amount Fair Value Level 1 Level 2 Level 3  Financial assets:  Cash and cash equivalents (1) $ 38,418 $ 38,418 $ 38,418 $ - $ -  Loans receivable, net 919,477 969,839 - - 969,839  Mortgage servicing rights 190 226 - - 226  Regulatory stock (1) 3,770 3,770 3,770 - -  Bank owned life insurance (1) 38,971 38,971 38,971 - -  Accrued interest receivable (1) 3,669 3,669 3,669 - -   Financial liabilities:  Deposits 990,160 994,357 612,778 - 381,579  Short-term borrowings (1) 40,656 40,656 40,656 - -  Other borrowings 51,350 52,410 - - 52,410  Accrued interest payable (1) 2,895 2,895 2,895 - -   Off-balance sheet financial instruments:  Commitments to extend credit and outstanding letters of credit - - - - -         Fair Value Measurements at December 31, 2019  Carrying Amount Fair Value Level 1 Level 2 Level 3  Financial assets:  Cash and cash equivalents (1) $ 15,415 $ 15,415 $ 15,415 $ - $ -  Loans receivable, net 916,072 943,143 - - 943,143  Mortgage servicing rights 187 226 - - 226  Regulatory stock (1) 4,844 4,844 4,844 - -  Bank owned life insurance (1) 38,763 38,763 38,763 - -  Accrued interest receivable (1) 3,719 3,719 3,719 - -   Financial liabilities:  Deposits 957,529 961,120 596,811 - 364,309  Short-term borrowings (1) 62,256 62,256 62,256 - -  Other borrowings 56,438 56,618 - - 56,618  Accrued interest payable (1) 2,432 2,432 2,432 - -   Off-balance sheet financial instruments:  Commitments to extend credit and outstanding letters of credit - - - - -        (1) This financial instrument is carried at cost, which approximates the fair value of the instrument.

New and Recently Adopted Accoun

New and Recently Adopted Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
New and Recently Adopted Accounting Pronouncements [Abstract]
New and Recently Adopted Accounting Pronouncements	11. New and Recently Adopted Accounting Pronouncements  New Accounting Pronouncements Not Yet Adopted  In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be effected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) . This Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements.  In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment . To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) , which deferred the effective date for ASC 350, Intangibles – Goodwill and Other , for smaller reporting companies to fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements.  In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits (Topic 715-20). This Update amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The Update eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The Update also removes the disclosure requirements for the effects of a one percentage point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. This Update is effective for public business entities for fiscal years ending after December 15, 2020, and must be applied on a retrospective basis. For all other entities, this Update is effective for fiscal years ending after December 15, 2021. This Update is not expected to have a significant impact on the Company’s financial statements.  In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825), which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. Topic 326 , Financial Instruments – Credit Losses , amendments are effective for SEC registrants for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other public business entities, the effective date is for fiscal years beginning after December 15, 2020, and for all other entities, the effective date is for fiscal years beginning after December 15, 2021. Topic 815 , Derivatives and Hedging , amendments are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods beginning after December 15, 2020. For entities that have adopted the amendments in Update 2017-12, the effective date is as of the beginning of the first annual period beginning after the issuance of this Update. Topic 825 , Financial Instruments , amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) . This Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Furthermore, the ASU provides a one-year deferral of the effective dates of the ASUs on derivatives and hedging for companies that are not public business entities. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.  In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326) , which allows entities to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost upon adoption of the new credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for applying the fair value option in ASC 825-10. The election must be applied on an instrument-by-instrument basis and is not available for either available-for-sale or held-to-maturity debt securities. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings. For entities that have not yet adopted ASU 2016-13, the effective dates and transition requirements are the same as those in ASU 2016-13. For entities that have adopted ASU 2016-13, ASU 2019-05 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted once ASU 2016-13 has been adopted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) . The Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt ASU 2016-13.  In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) . The Update defers the effective dates of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This Update also amends the mandatory effective date for the elimination of Step 2 from the goodwill impairment test under ASU No. 2017-04, Intangibles ‒ Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (Goodwill) , to align with those used for credit losses. Furthermore, the ASU provides a one-year deferral of the effective dates of the ASUs on derivatives and hedging and leases for companies that are not public business entities. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.  In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , to clarify its new credit impairment guidance in ASC 326, based on implementation issues raised by stakeholders. This Update clarified, among other things, that expected recoveries are to be included in the allowance for credit losses for these financial assets; an accounting policy election can be made to adjust the effective interest rate for existing troubled debt restructurings based on the prepayment assumptions instead of the prepayment assumptions applicable immediately prior to the restructuring event; and extends the practical expedient to exclude accrued interest receivable from all additional relevant disclosures involving amortized cost basis. The effective dates in this Update are the same as those applicable for ASU 2019-10. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.  In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) , to simplify the accounting for income taxes, change the accounting for certain tax transactions, and make minor improvements to the codification. This Update provides a policy election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax and provides guidance to evaluate whether a step-up in tax basis of goodwill relates to a business combination in which book goodwill was recognized or was a separate transaction. The Update also changes current guidance for making an intraperiod allocation if there is a loss in continuing operations and gains outside of continuing operations, determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting, accounting for tax law changes and year-to-date losses in interim periods, and determining how to apply the income tax guidance to franchise taxes that are partially based on income. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements.  In January 2020, the FASB issued ASU 2020-2, Financial Instruments – Credit Losses (Topic 326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), February 2020 , to add and amend SEC paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 119, related to the new credit losses standard, and comments by the SEC staff related to the revised effective date of the new leases standard. This ASU is effective upon issuance. This did not have a significant impact on the Company’s financial statements.  In March 2020, the FASB issued ASU 2020-3 , Codification Improvements to Financial Instruments. This ASU was issued to improve and clarify various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven issues that describe the areas of improvement and the related amendments to GAAP; they are intended to make the standards easier to understand and apply and to eliminate inconsistencies, and they are narrow in scope and are not expected to significantly change practice for most entities. Among its provisions, the ASU clarifies that all entities, other than public business entities that elected the fair value option, are required to provide certain fair value disclosures under ASC 825, Financial Instruments , in both interim and annual financial statements. It also clarifies that the contractual term of a net investment in a lease under Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. Amendments related to ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is not permitted before an entity’s adoption of ASU 2016-01. Amendments related to ASU 2016-13 for entities that have not yet adopted that guidance are effective upon adoption of the amendments in ASU 2016-13. Early adoption is not permitted before an entity’s adoption of ASU 2016-13. Amendments related to ASU 2016-13 for entities that have adopted that guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Other amendments are effective upon issuance of this ASU. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations.  In January 2020, the FASB issued ASU 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020 , to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform, if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform, if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations.  

Proposed Acquisition of UpState

Proposed Acquisition of UpState New York Bancorp, Inc.	3 Months Ended
	Mar. 31, 2020
Proposed Acquisition of UpState New York Bancorp, Inc. [Abstract]
Proposed Acquisition of UpState New York Bancorp, Inc.	12. Proposed Acquisition of UpState New York Bancorp, Inc.  On January 8, 2020, Norwood Financial Corp. (“Norwood”) and its wholly owned subsidiary, Wayne Bank, and UpState New York Bancorp, Inc. (“UpState”), and its wholly owned subsidiary, USNY Bank entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which UpState will merge with and into Norwood, with Norwood as the surviving corporation. Concurrent with the merger, it is expected that USNY Bank will merge with and into Wayne Bank.  USNY Bank conducts its business from its two Bank of the Finger Lakes offices in Geneva and Penn Yan, New York, and two Bank of Cooperstown offices in Cooperstown and Oneonta, New York. As of December 31, 2019, UpState had total assets of $439.6 million, total net loans of $380.7 million, total deposits of $387.9 million and total stockholders’ equity of $46.4 million. Pursuant to the terms of the Merger Agreement, shareholders of UpState will have the opportunity to elect to receive for each share of UpState common stock they own, either 0.9390 shares of Norwood common stock or $33.33 in cash, or a combination of both. All shareholder elections will be subject to the allocation and proration procedures set forth in the Merger Agreement which are intended to ensure that 90% of the shares of UpState will be exchanged for Norwood common stock and 10% of the shares of UpState will be exchanged for cash. In addition to the purchase price per share, UpState may also be permitted, under certain performance conditions, to distribute at the closing of the merger, a special cash dividend of up to an additional $0.67 per s hare to UpState’s shareholders. In the event of a greater than 20% decline in market value of Norwood’s common stock, UpState may, in certain circumstances, be able to terminate the Merger Agreement unless Norwood increases the number of shares into which UpState common stock may be converted.  The senior management of Norwood and Wayne Bank will remain the same following the merger. UpState directors Jeffrey S. Gifford and Alexandra K. Nolan will be appointed to the boards of directors of Norwood and Wayne Bank. In addition, the other directors of UpState will be invited to join a regional advisory board. UpState President and CEO R. Michael Briggs will enter into a consulting agreement with Wayne Bank. Norwood will retain the brand names of USNY’s two units, Bank of the Finger Lakes and Bank of Cooperstown, and will also retain USNY’s administration center in Geneva, New York. Scott D. White, unit President of Bank of Cooperstown, and Jeffrey E. Franklin, unit President of Bank of the Finger Lakes, will also remain in place as executives of their units.  The merger is subject to customary closing conditions, including the receipt of regulatory approvals and approval by the shareholders of Norwood and UpState. The merger is expected to be completed in the third quarter of 2020.

Risks and Uncertainties

Risks and Uncertainties	3 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Risks and Uncertainties	13. Risks and Uncertainties  The Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was signed into law on March 27, 2020, and provides over $2.0 trillion in emergency economic relief to individuals and businesses impacted by the COVID-19 pandemic. The CARES Act authorized the Small Business Administration (“SBA”) to temporarily guarantee loans under a new 7(a) loan program called the Paycheck Protection Program (“PPP”). As a qualified SBA lender, we were automatically authorized to originate PPP loans.  An eligible business can apply for a PPP loan up to the greater of: (1) 2.5 times its average monthly payroll costs; or (2) $10.0 million. PPP loans will have: (a) an interest rate of 1.0%, (b) a two-year loan term to maturity; and (c) principal and interest payments deferred for six months from the date of disbursement. The SBA will guarantee 100% of the PPP loans made to eligible borrowers. The entire principal amount of the borrower’s PPP loan, including any accrued interest, is eligible to be reduced by the loan forgiveness amount under the PPP so long as employee and compensation levels of the business are maintained and 75% of the loan proceeds are used for payroll expenses, with the remaining 25% of the loan proceeds used for other qualifying expenses. As of April 30 , 2020, we approved 472 applications for $59.2 million of loans under the PPP.  Since the opening of the PPP, several larger banks have been subject to litigation regarding the process and procedures that such banks used in processing applications for the PPP. Norwood may be exposed to the risk of similar litigation, from both customers and non-customers that approached the bank regarding PPP loans, regarding the process and procedures used in processing applications for the PPP. If any such litigation is filed against and is not resolved in a manner favorable to Norwood , it may result in significant financial liability or adversely affect reputation. In addition, litigation can be costly, regardless of outcome. Any financial liability, litigation costs or reputational damage caused by PPP-related litigation could have a material adverse impact on our business, financial condition and results of operations.  The Company also has credit risk on PPP loans if a determination is made by the SBA that there is a deficiency in the manner in which the loan was originated, funded, or serviced by, such as an issue with the eligibility of a borrower to receive a PPP loan, which may or may not be related to the ambiguity in the laws, rules and guidance regarding the operation of the PPP. In the event of a loss resulting from a default on a PPP loan and a determination by the SBA that there was a deficiency in the manner in which the PPP loan was originated, funded, or serviced by Norwood , the SBA may deny its liability under the guaranty, reduce the amount of the guaranty, or, if it has already paid under the guaranty, seek recovery of any loss related to the deficiency from the Company.  Owner-Occupied Residential Mortgage & Consumer Loans . For residential mortgage and consumer loans, CARES Act Section 4013 forbearance agreements are available to qualified borrowers. As of April 30 , 2020, we had processed 151 residential mortgage payment deferrals of $10.4 million . None of the deferrals granted were to non-owner-occupied loans. Due to the widespread impact of the State of Pennsylvania and the State of New York Stay At Home order s , we expect that additional residential loan borrowers will seek loan forbearance or loan modification agreements in the second quarter of 2020.  Deferrals  As of April 30, 2020, we received requests to modify 754 loans aggregating $165.4 million primarily consisting of the deferral of principal and interest payments and the extension of the maturity date.  Details with respect to actual loan modifications are as follows:  COVID-19 Loan Forbearance Programs . Section 4013 of the CARES Act provides that banks may elect not to categorize a loan modification as a TDR if the loan modification is (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (A) 60 days after the date on which the national emergency concerning the novel coronavirus disease (COVID–19) outbreak declared by the President on March 13, 2020, under the National Emergencies Act terminates, or (B) December 31, 2020. According to the Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus (Revised) issued by the federal bank regulatory agencies on April 7, 2020, short-term loan modifications not otherwise eligible under Section 4013 that are made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. See Note 8 of the financial statements for additional disclosure of TDRs at March 31, 2020.  The following table presents a summary of loan forbearance by type of loan as of April 30, 2020:  Number of Loan Type Loans Balance (in thousands)  Real Estate Loans: Residential 152 $ 10,359 Commercial 167 129,851 Construction 14 5,005 Commercial, financial and agricultural 60 11,797 Consumer loans to individuals 361 8,348 Total 754 $ 165,360 

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue Recognition [Abstract]
Noninterest Income	    Three months ended  March 31,   (dollars in thousands)   Noninterest Income 2020 2019  In-scope of Topic 606:  Service charges on deposit accounts $ 96 $ 67  ATM fees 95 90  Overdraft fees 344 351  Safe deposit box rental 29 26  Loan related service fees 100 129  Debit card fees 344 326  Fiduciary activities 153 142  Commissions on mutual funds and annuities 38 55  Other income 132 115  Noninterest Income ( in-scope of Topic 606 ) 1,331 1,301   Out-of-scope of Topic 606:  Net realized gains on sales of securities 38 -  Loan servicing fees 21 15  Gains on sales of loans 56 42  Earnings on and proceeds from bank-owned life insurance 208 202  Noninterest Income ( out-of-scope of Topic 606 ) 323 259  Total Noninterest Income $ 1,654 $ 1,560    

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule Of Weighted Average Shares Outstanding Used In The Computations Of Basic And Diluted Earnings Per Share	  (in thousands) Three Months Ended  March 31,  2020 2019  Weighted average shares outstanding 6,330 6,293  Less: Unvested restricted shares (36) (34)  Basic EPS weighted average shares outstanding 6,294 6,259    Basic EPS weighted average shares outstanding 6,294 6,259  Add: Dilutive effect of stock options and restricted shares 29 50  Diluted EPS weighted average shares outstanding 6,323 6,309 

Stock Based Compensation (Table

Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Stock Based Compensation [Abstract]
Summary of Stock Option Activity	   Weighted  Average Exercise Weighted Average Aggregate  Price Remaining Intrinsic Value  Options Per Share Contractual Term ($000)   Outstanding at January 1, 2020 199,825 $ 24.78 5.9 Yrs. $ 2,822  Granted - - - -  Exercised (2,005) 19.25 5.8 Yrs. 33  Forfeited - - -  Outstanding at March 31, 2020 197,820 $ 24.83 5.7 Yrs. $ 370   Exercisable at March 31, 2020 171,070 $ 23.08 5.0 Yrs. $ 620 
Summary of Restricted Stock Activity	  2020 2019  Weighted-Average Weighted-Average  Number of Grant Date Number of Grant Date  Restricted Stock Fair Value Restricted Stock Fair Value  Non-vested, January 1, 36,195 $ 36.23 34,615 $ 27.82  Granted - - - -  Vested - - - -  Forfeited - - - -  Non-vested, March 30, 36,195 $ 36.23 34,615 $ 27.82 

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Abstract]
Summary of Changes In Accumulated Other Comprehensive Income (Loss)	        Unrealized gains (losses) on  available for sale  securities (a)  Balance as of December 31, 2019 $ 1,187  Other comprehensive income before reclassification 3,120  Amount reclassified from accumulated other comprehensive income (30)  Total other comprehensive income 3,090  Balance as of March 31, 2020 $ 4,277    Unrealized gains (losses) on  available for sale  securities (a)  Balance as of December 31, 2018 $ (5,020)  Other comprehensive loss before reclassification 2,943  Amount reclassified from accumulated other comprehensive loss -  Total other comprehensive loss 2,943  Balance as of March 31, 2019 $ (2,077)                (a) All amounts are net of tax. Amounts in parentheses indicate debits.
Significant Amounts Reclassified Out of Each Component of Accumulated Other Comprehensive Income (Loss)	           Amount Reclassified  From Accumulated Affected Line Item in  Other Consolidated  Comprehensive Statements  Details about other comprehensive income Income (Loss) (a) of Income   Three months ended  March 31,  2020 2019  Unrealized gains on available for sale securities $ 38 $ - Net realized gains on sales of securities  (8) - Income tax expense  $ 30 $ -   (a) Amounts in parentheses indicate debits to net income

Off-Balance Sheet Financial I_2

Off-Balance Sheet Financial Instruments and Guarantees (Tables)	3 Months Ended
	Mar. 31, 2020
Off-Balance Sheet Financial Instruments and Guarantees [Abstract]
Schedule of Fair Value, Off-balance Sheet Risks	   (in thousands) March 31,  2020 2019   Commitments to grant loans $ 55,036 $ 40,322  Unfunded commitments under lines of credit 68,530 77,573  Standby letters of credit 4,065 4,183  $ 127,631 $ 122,078 

Securities (Tables)

Securities (Tables)	3 Months Ended
	Mar. 31, 2020
Securities [Abstract]
Schedule of Amortized Cost Gross Unrealized Gains and Losses, and Fair Values of Securities	   March 31, 2020  Gross Gross  Amortized Unrealized Unrealized Fair  Cost Gains Losses Value  (In Thousands)  Available for Sale:  States and political subdivisions $ 58,182 $ 1,340 $ (1) $ 59,521  Corporate obligations 3,076 - (11) 3,065  Mortgage-backed securities-  government sponsored entities 131,382 3,030 - 134,412  Total debt securities $ 192,640 $ 4,370 $ (12) $ 196,998      December 31, 2019  Gross Gross  Amortized Unrealized Unrealized Fair  Cost Gains Losses Value   (In Thousands)  Available for Sale:  States and political subdivisions $ 70,015 $ 1,293 $ (3) $ 71,305  Corporate obligations 4,097 3 - 4,100  Mortgage-backed securities-government  sponsored entities 135,646 238 (1,084) 134,800  Total debt securities $ 209,758 $ 1,534 $ (1,087) $ 210,205     
Schedule of Investments' Gross Unrealized Losses and Fair Value Aggregated by Security Type and Length of Time that Individual Securities have been in a Continous Unrealized Loss Position	   March 31, 2019  Less than 12 Months 12 Months or More Total  Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses  States and political subdivisions $ 1,195 $ (1) $ - $ - $ 1,195 $ (1)  Corporate obligations 3,065 (11) - - 3,065 (11)  $ 4,260 $ (12) $ - $ - $ 4,260 $ (12)      December 31, 2019  Less than 12 Months 12 Months or More Total  Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses  States and political subdivisions $ 1,296 $ (2) $ 481 $ (1) $ 1,777 $ (3)  Mortgage-backed securities-government sponsored entities 32,415 (241) 61,096 (843) 93,511 (1,084)  $ 33,711 $ (243) $ 61,577 $ (844) $ 95,288 $ (1,087) 
Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity	   Available for Sale  Amortized Cost Fair Value  (In Thousands)   Due in one year or less $ 2,742 $ 2,747  Due after one year through five years 10,370 10,377  Due after five years through ten years 20,876 21,091  Due after ten years 27,270 28,371  61,258 62,586  Mortgage-backed securities-government sponsored entities 131,382 134,412  $ 192,640 $ 196,998 
Gross Realized Gains and Losses on Sales of Securities Available-for-Sale	   Three Months  Ended March 31,  2020 2019  Gross realized gains $ 38 $ -  Gross realized losses - -  Net realized gain $ 38 $ -  Proceeds from sales of securities $ 8,224 $ 327 

Loans Receivable and Allowanc_2

Loans Receivable and Allowance for Loan Losses (Tables)	3 Months Ended
	Mar. 31, 2020
Loans Receivable and Allowance for Loan Losses [Abstract]
Composition of the Loan Portfolio	      March 31, 2020 December 31, 2019  Real Estate Loans:  Residential $ 227,373 24.5 % $ 229,781 24.9 %  Commercial 398,492 42.9 391,327 42.3  Construction 16,622 1.8 17,732 1.9  Commercial, financial and agricultural 132,716 14.3 134,150 14.5  Consumer loans to individuals 153,394 16.5 151,686 16.4  Total loans 928,597 100.0 % 924,676 100.0 %  Deferred fees, net (32) (95)  Total loans receivable 928,565 924,581  Allowance for loan losses (9,088) (8,509)  Net loans receivable $ 919,477 $ 916,072 
Information Regarding Loans Acquired and Accounted for in Accordance With ASC 310-30	   March 31, 2020 December 31, 2019   Outstanding Balance $ 777 $ 793  Carrying Amount $ 680 $ 696 
Summary of Amount of Loans in Each Category that were Individually and Collectively Evaluated for Impairment	   Real Estate Loans  Commercial Consumer  Residential Commercial Construction Loans Loans Total  March 31, 2020 (In thousands)   Individually evaluated for impairment $ - $ 2,096 $ - $ - $ - $ 2,096  Loans acquired with deteriorated credit quality 467 213 - - - 680  Collectively evaluated for impairment 226,906 396,183 16,622 132,716 153,394 925,821  Total Loans $ 227,373 $ 398,492 $ 16,622 $ 132,716 $ 153,394 $ 928,597      Real Estate Loans  Commercial Consumer  Residential Commercial Construction Loans Loans Total  (In thousands)  December 31, 2019   Individually evaluated for impairment $ - $ 2,144 $ - $ - $ - $ 2,144  Loans acquired with deteriorated credit quality 476 220 - - - 696  Collectively evaluated for impairment 229,305 388,963 17,732 134,150 151,686 921,836  Total Loans $ 229,781 $ 391,327 $ 17,732 $ 134,150 $ 151,686 $ 924,676 
Impaired Loans and Related Interest Income by Loan Portfolio Class	The following table includes the recorded investment and unpaid principal balances for impaired loans with the associated allowance amount, if applicable.     Unpaid  Recorded Principal Associated  Investment Balance Allowance  March 31, 2020 (in thousands)  With no related allowance recorded:  Real Estate Loans:  Commercial $ 173 $ 173 $ -  Subtotal 173 173 -   With an allowance recorded:  Real Estate Loans  Commercial 1,923 1,923 392  Subtotal 1,923 1,923 392   Total:  Real Estate Loans:  Commercial 2,096 2,096 392  Total Impaired Loans $ 2,096 $ 2,096 $ 392      Unpaid  Recorded Principal Associated  Investment Balance Allowance  December 31, 2019 (in thousands)  With no related allowance recorded:  Real Estate Loans:  Commercial $ 143 $ 394 $ -  Subtotal 143 394 -   With an allowance recorded:  Real Estate Loans  Commercial 2,001 2,001 417  Subtotal 2,001 2,001 417  Total:  Real Estate Loans:  Commercial 2,144 2,395 417  Total Impaired Loans $ 2,144 $ 2,395 $ 417  The following table presents the average recorded investment in impaired loans and the related amount of interest income recognized during the three-month periods ended March 31, 2020 and 2019, respectively (in thousands):       Average Recorded Interest Income  Investment Recognized  2020 2019 2020 2019   Real Estate Loans:  Commercial 2,098 885 3 -  Total $ 2,098 $ 885 $ 3 $ -     
Classes of the Loan Portfolio Summarized by the Aggregate Risk Rating	    Special Doubtful  Pass Mention Substandard or Loss Total  March 31, 2020  Commercial real estate loans $ 384,948 $ 10,633 $ 2,911 $ - $ 398,492  Commercial loans 132,248 240 228 - 132,716  Total $ 517,196 $ 10,873 $ 3,139 $ - $ 531,208        Special Doubtful  Pass Mention Substandard or Loss Total  December 31, 2019  Commercial real estate loans $ 376,109 $ 12,268 $ 2,950 $ - $ 391,327  Commercial loans 133,695 248 207 - 134,150  Total $ 509,804 $ 12,516 $ 3,157 $ - $ 525,477  For residential real estate loans, construction loans and consumer loans, the Company evaluates credit quality based on the performance of the individual credits. The following table presents the recorded investment in the loan classes based on payment activity as of March 31, 2020 and December 31, 2019 (in thousands):      Performing Nonperforming Total  March 31, 2020  Residential real estate loans $ 226,894 $ 479 $ 227,373  Construction 16,622 - 16,622  Consumer loans 153,226 168 153,394  Total $ 396,742 $ 647 $ 397,389      Performing Nonperforming Total  December 31, 2019  Residential real estate loans $ 229,214 $ 567 $ 229,781  Construction 17,732 - 17,732  Consumer loans 151,607 79 151,686  Total $ 398,553 $ 646 $ 399,199 
Loan Portfolio Summarized by the Past Due Status	   Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Total Loans  March 31, 2020  Real Estate loans  Residential $ 225,840 $ 849 $ 205 $ - $ 479 $ 1,533 $ 227,373  Commercial 395,516 784 149 - 2,043 2,976 398,492  Construction 16,622 - - - - - 16,622  Commercial loans 132,623 - 40 - 53 93 132,716  Consumer loans 152,770 342 114 - 168 624 153,394  Total $ 923,371 $ 1,975 $ 508 $ - $ 2,743 $ 5,226 $ 928,597        Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Total Loans  December 31, 2019  Real Estate loans  Residential $ 228,242 $ 727 $ 245 $ - $ 567 $ 1,539 $ 229,781  Commercial 388,117 176 2,935 - 99 3,210 391,327  Construction 17,695 - 37 - - 37 17,732  Commercial loans 134,018 82 - - 50 132 134,150  Consumer loans 151,309 233 65 - 79 377 151,686  Total $ 919,381 $ 1,218 $ 3,282 $ - $ 795 $ 5,295 $ 924,676 
Allowance for Loan Losses and Recorded Investment in Financing Receivables	           (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total  Beginning balance, December 31, 2019 $ 1,552 $ 4,687 $ 95 $ 949 $ 1,226 $ 8,509  Charge Offs (1) (33) - - (116) (150)  Recoveries 2 4 - 10 13 29  Provision for loan losses 91 257 (8) 105 255 700  Ending balance, March 31, 2020 $ 1,644 $ 4,915 $ 87 $ 1,064 $ 1,378 $ 9,088  Ending balance individually evaluated for impairment $ - $ 392 $ - $ - $ - $ 392  Ending balance collectively evaluated for impairment $ 1,644 $ 4,523 $ 87 $ 1,064 $ 1,378 $ 8,696            (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total  Beginning balance, December 31, 2018 $ 1,328 $ 5,455 $ 93 $ 712 $ 864 $ 8,452  Charge Offs (65) (469) - (1) (63) (598)  Recoveries 11 10 - 10 14 45  Provision for loan losses 181 (49) 15 90 213 450  Ending balance, March 31, 2019 $ 1,455 $ 4,947 $ 108 $ 811 $ 1,028 $ 8,349  Ending balance individually evaluated for impairment $ - $ - $ - $ - $ - $ -  Ending balance collectively evaluated for impairment $ 1,455 $ 4,947 $ 108 $ 811 $ 1,028 $ 8,349 

Operating Leases (Tables)

Operating Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Operating Leases [Abstract]
Lease Cost	  Operating  Weighted-average remaining term 12.9  Weighted-average discount rate 3.21% 
Undiscounted Cash Flows Due	 Undiscounted cash flows due (in thousands) Operating   2020 $ 401  2021 535  2022 535  2023 535  2024 544  2025 and thereafter 3,879  Total undiscounted cash flows 6,429  Discount on cash flows (1,204)  Total lease liabilities $ 5,225 

Fair Value of Assets and Liab_2

Fair Value of Assets and Liabilities (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value of Assets and Liabilities [Abstract]
Fair Value, Assets Measured on Recurring Basis	      Fair Value Measurement Using  Reporting Date    Description Total Level 1 Level 2 Level 3  (In thousands)   March 31, 2020  Available for Sale:  States and political subdivisions $ 59,521 $ - $ 59,521 $ -  Corporate obligations 3,065 - 3,065 -  Mortgage-backed securities-government  sponsored entities 134,412 - 134,412 -  Total $ 196,998 $ - $ 196,998 $ -    Description Total Level 1 Level 2 Level 3  (In thousands)   December 31, 2019  Available for Sale:  States and political subdivisions $ 71,305 $ - $ 71,305 $ -  Corporate obligations 4,100 - 4,100 -  Mortgage-backed securities-government  sponsored entities 134,800 - 134,800 -  Total $ 210,205 $ - $ 210,205 $ - 
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis	   Fair Value Measurement Using Reporting Date   (In thousands)   Description Total Level 1 Level 2 Level 3  March 31, 2020  Impaired Loans $ 1,531 $ - $ - $ 1,531  Foreclosed Real Estate Owned 1,077 - - 1,077    December 31, 2019  Impaired Loans $ 1,584 $ - $ - $ 1,584  Foreclosed Real Estate Owned 1,556 - - 1,556 
Additional Qualitative Information about Level 3 Assets	  Quantitative Information about Level 3 Fair Value Measurements  (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average)  March 31, 2020  Impaired loans $ 1,531 Appraisal of collateral(1) Appraisal adjustments(2) 10.00% ( 10.00% )   Foreclosed real estate owned $ 1,077 Appraisal of collateral(1) Liquidation Expenses(2) 0 -7.00% ( 6.27% )       Quantitative Information about Level 3 Fair Value Measurements  (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average)  December 31, 2019  Impaired loans $ 1,531 Appraisal of collateral(1) Appraisal adjustments(2) 10.00% ( 10.00% )  Impaired loans $ 53 Present value of future cash flows Loan discount rate 4.00 -6.97% ( 5.55% )  Probability of default 0%   Foreclosed real estate owned $ 1,556 Appraisal of collateral(1) Liquidation Expenses(2) 0 -7.00% ( 4.34% )  (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level 3 inputs which are not identifiable, less any associated allowance. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.
Fair Value, by Balance Sheet Grouping	     Fair Value Measurements at March 31, 2020  Carrying Amount Fair Value Level 1 Level 2 Level 3  Financial assets:  Cash and cash equivalents (1) $ 38,418 $ 38,418 $ 38,418 $ - $ -  Loans receivable, net 919,477 969,839 - - 969,839  Mortgage servicing rights 190 226 - - 226  Regulatory stock (1) 3,770 3,770 3,770 - -  Bank owned life insurance (1) 38,971 38,971 38,971 - -  Accrued interest receivable (1) 3,669 3,669 3,669 - -   Financial liabilities:  Deposits 990,160 994,357 612,778 - 381,579  Short-term borrowings (1) 40,656 40,656 40,656 - -  Other borrowings 51,350 52,410 - - 52,410  Accrued interest payable (1) 2,895 2,895 2,895 - -   Off-balance sheet financial instruments:  Commitments to extend credit and outstanding letters of credit - - - - -         Fair Value Measurements at December 31, 2019  Carrying Amount Fair Value Level 1 Level 2 Level 3  Financial assets:  Cash and cash equivalents (1) $ 15,415 $ 15,415 $ 15,415 $ - $ -  Loans receivable, net 916,072 943,143 - - 943,143  Mortgage servicing rights 187 226 - - 226  Regulatory stock (1) 4,844 4,844 4,844 - -  Bank owned life insurance (1) 38,763 38,763 38,763 - -  Accrued interest receivable (1) 3,719 3,719 3,719 - -   Financial liabilities:  Deposits 957,529 961,120 596,811 - 364,309  Short-term borrowings (1) 62,256 62,256 62,256 - -  Other borrowings 56,438 56,618 - - 56,618  Accrued interest payable (1) 2,432 2,432 2,432 - -   Off-balance sheet financial instruments:  Commitments to extend credit and outstanding letters of credit - - - - -        (1) This financial instrument is carried at cost, which approximates the fair value of the instrument.

Risks and Uncertainties (Tables

Risks and Uncertainties (Tables)	3 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Summary of Loan Forbearance	Number of Loan Type Loans Balance (in thousands)  Real Estate Loans: Residential 152 $ 10,359 Commercial 167 129,851 Construction 14 5,005 Commercial, financial and agricultural 60 11,797 Consumer loans to individuals 361 8,348 Total 754 $ 165,360

Revenue Recognition (Noninteres

Revenue Recognition (Noninterest Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Noninterest Income (in scope of Topic 606)	$ 1,331	$ 1,301
Net realized gains on sales of securities	38	0
Loan servicing fees	21	15
Gain on sales of loans	56	42
Earnings on and proceeds from bank-owned life insurance	208	202
Noninterest Income (out-of-scope of Topic 606)	323	259
Total other income	1,654	1,560
Service Charges On Deposit Accounts [Member]
Noninterest Income (in scope of Topic 606)	96	67
ATM Fees [Member]
Noninterest Income (in scope of Topic 606)	95	90
Overdraft Fees [Member]
Noninterest Income (in scope of Topic 606)	344	351
Safe Deposit Box Rental [Member]
Noninterest Income (in scope of Topic 606)	29	26
Loan Related Service Fees [Member]
Noninterest Income (in scope of Topic 606)	100	129
Debit Card [Member]
Noninterest Income (in scope of Topic 606)	344	326
Fiduciary Activities [Member]
Noninterest Income (in scope of Topic 606)	153	142
Commissions On Mutual Funds And Annuities [Member]
Noninterest Income (in scope of Topic 606)	38	55
Other Income [Member]
Noninterest Income (in scope of Topic 606)	$ 132	$ 115

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	82,600	60,650
Share price	$ 26.70	$ 30.84	$ 38.90

Earnings Per Share (Schedule of

Earnings Per Share (Schedule of Weighted Average Shares Outstanding Used in the Computations of Basic and Diluted Earnings Per Share) (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Weighted average shares outstanding	6,330	6,293
Less: Unvested restricted shares	(36)	(34)
Basic EPS weighted average shares outstanding	6,294	6,259
Add: Dilutive effect of stock options and restricted shares	29	50
Diluted EPS weighted average shares outstanding	6,323	6,309

Stock Based Compensation (Narra

Stock Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, Granted	0
Share price	$ 26.70	$ 30.84	$ 38.90
Future compensation expense of non-vested restricted stock outstanding	$ 1,062
Non-vested restricted stock recognition period	4 years 9 months
Compensation expense related to stock options	$ 51	$ 52
Non-vested stock outstanding	36,195	34,615	36,195	34,615
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 84	$ 72
Norwood Financial Corp 2014 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested options granted	$ 153

Stock Based Compensation (Summa

Stock Based Compensation (Summary of Stock Option Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Stock Based Compensation [Abstract]
Options, beginning of year	199,825
Options, Granted	0
Options, Exercised	(2,005)
Options, Forfeited	0
Options, end of year	197,820	199,825
Options, Exercisable, end of period	171,070
Weighted Average Exercise Price Per Share, Outstanding, beginning of period	$ 24.78
Weighted Average Exercise Price Per Share, Granted
Weighted Average Exercise Price Per Share, Exercised	19.25
Weighted Average Exercise Price Per Share, Forfeited	0
Weighted Average Exercise Price Per Share, Outstanding, end of period	24.83	$ 24.78
Weighted Average Exercise Price Per Share, Exercisable, end of period	$ 23.08
Weighted Average Remaining Contractual Term, Granted in Period	5 years 9 months 18 days
Weighted Average Remaining Contractual Term, Outstanding	5 years 8 months 12 days	5 years 10 months 24 days
Weighted Average Remaining Contractual Term, Exercisable at End of Period	5 years
Aggregate Intrinsic Value, Outstanding, beginning of period	$ 2,822
Aggregate Intrinsic Value, Granted in Period	0
Aggregate Intrinsic Value, Exercised in Period	33
Aggregate Intrinsic Value, Forfeited in Period	0
Aggregate Intrinsic Value, Outstanding, end of period	370	$ 2,822
Aggregate Intrinsic Value, Exercisable at end of period	$ 620

Stock Based Compensation (Sum_2

Stock Based Compensation (Summary of Restricted Stock Activity) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock Based Compensation [Abstract]
Restricted stock Non-vested, beginning balance	36,195	34,615
Restricted stock, granted	0	0
Restricted stock, vested	0	0
Restricted stock, forfeited	0	0
Restricted stock Non-vested, ending balance	36,195	34,615
Restricted stock Non-vested, weighted-average grant date fair value, beginning balance	$ 36.23	$ 27.82
Restricted stock, granted, weighted-average grant date fair value	0	0
Restricted stock, vested, weighted-average grant date fair value	0	0
Restricted stock, forfeited, weighted-average grant date fair value	0	0
Restricted stock Non-vested, weighted-average grant date fair value, ending balance	$ 36.23	$ 27.82

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Summary Of Changes In Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ 1,187
Other comprehensive income	3,090	$ 2,943
Ending balance	4,277
Unrealized gains and losses on available-for-sale securities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	1,187	(5,020)
Other comprehensive income (loss) before reclassification	3,120	2,943
Other comprehensive income	3,090	2,943
Ending balance	4,277	(2,077)
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income	3,090	2,943
Amount Reclassified From Accumulated Other Comprehensive Income (Loss) [Member] | Unrealized gains and losses on available-for-sale securities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amount reclassified from accumulated other comprehensive (income) loss	$ (30)	$ 0

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) (Significant Amounts Reclassified Out Of Each Component Of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net realized gains on sales of securities	$ 38	$ 0
Income tax expense	(481)	(543)
NET INCOME	3,079	3,190
Amount Reclassified From Accumulated Other Comprehensive Income (Loss) [Member] | Unrealized gains and losses on available-for-sale securities [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net realized gains on sales of securities	38	0
Income tax expense	(8)	0
NET INCOME	$ 30	$ 0

Off-Balance Sheet Financial I_3

Off-Balance Sheet Financial Instruments and Guarantees (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Mar. 31, 2019
Loss Contingencies [Line Items]
Financial instrument commitments	$ 127,631	$ 122,078
Commitments to grant loans [Member]
Loss Contingencies [Line Items]
Financial instrument commitments	55,036	40,322
Unfunded commitments under lines of credit [Member]
Loss Contingencies [Line Items]
Financial instrument commitments	68,530	77,573
Standby letters of credit [Member]
Loss Contingencies [Line Items]
Financial instrument commitments	$ 4,065	$ 4,183

Securities (Narrative) (Details

Securities (Narrative) (Details)	3 Months Ended
	Mar. 31, 2020USD ($)security	Mar. 31, 2019USD ($)
Securities [Abstract]
Debt securities in unrealized loss position in the less than twelve months category | security	5
Impairment of investments	$ 0
Pledged Financial Instruments, Not Separately Reported, Securities	$ 177,342,000	$ 196,137,000

Securities (Schedule of Amortiz

Securities (Schedule of Amortized Cost Gross Unrealized Gains and Losses, and Fair Values of Securities) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Schedule of Investments [Line Items]
Available for Sale, Gross Unrealized Gains	$ 0	$ 0
Available for Sale, Gross Unrealized Losses	0	0
Available for Sale, Fair Value	196,998	210,205
Fixed income [Member]
Schedule of Investments [Line Items]
Available for Sale, Amortized Cost	192,640	209,758
Available for Sale, Gross Unrealized Gains	4,370	1,534
Available for Sale, Gross Unrealized Losses	(12)	(1,087)
Available for Sale, Fair Value	196,998	210,205
States And Political Subdivisions [Member]
Schedule of Investments [Line Items]
Available for Sale, Amortized Cost	58,182	70,015
Available for Sale, Gross Unrealized Gains	1,340	1,293
Available for Sale, Gross Unrealized Losses	(1)	(3)
Available for Sale, Fair Value	59,521	71,305
Corporate Obligations [Member]
Schedule of Investments [Line Items]
Available for Sale, Amortized Cost	3,076	4,097
Available for Sale, Gross Unrealized Gains	0	3
Available for Sale, Gross Unrealized Losses	(11)	0
Available for Sale, Fair Value	3,065	4,100
Mortgage-backed Securities-Government Sponsored Entities [Member]
Schedule of Investments [Line Items]
Available for Sale, Amortized Cost	131,382	135,646
Available for Sale, Gross Unrealized Gains	3,030	238
Available for Sale, Gross Unrealized Losses	0	(1,084)
Available for Sale, Fair Value	$ 134,412	$ 134,800

Securities (Schedule of Investm

Securities (Schedule of Investments' Gross Unrealized Losses and Fair Value Aggregated by Security Type and Length of Time that Individual Securities have been in a Continuous Unrealized Loss Position) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Schedule of Investments [Line Items]
Less than 12 Months, Fair Value	$ 4,260	$ 33,711
Less than 12 Months, Unrealized Losses	(12)	(243)
12 Months or More, Fair Value	0	61,577
12 Months or More, Unrealized Losses	0	(844)
Total, Fair Value	4,260	95,288
Total, Unrealized Losses	(12)	(1,087)
States And Political Subdivisions [Member]
Schedule of Investments [Line Items]
Less than 12 Months, Fair Value	1,195	1,296
Less than 12 Months, Unrealized Losses	(1)	(2)
12 Months or More, Fair Value	0	481
12 Months or More, Unrealized Losses	0	(1)
Total, Fair Value	1,195	1,777
Total, Unrealized Losses	(1)	(3)
Corporate Obligations [Member]
Schedule of Investments [Line Items]
Less than 12 Months, Fair Value	3,065
Less than 12 Months, Unrealized Losses	(11)
12 Months or More, Fair Value	0
12 Months or More, Unrealized Losses	0
Total, Fair Value	3,065
Total, Unrealized Losses	$ (11)
Mortgage-backed Securities-Government Sponsored Entities [Member]
Schedule of Investments [Line Items]
Less than 12 Months, Fair Value		32,415
Less than 12 Months, Unrealized Losses		(241)
12 Months or More, Fair Value		61,096
12 Months or More, Unrealized Losses		(843)
Total, Fair Value		93,511
Total, Unrealized Losses		$ (1,084)

Securities (Schedule of Amort_2

Securities (Schedule of Amortized Cost and Fair Value Of Debt Securities by Contractual Maturity) (Details) $ in Thousands	Mar. 31, 2020USD ($)
Securities [Abstract]
Available for Sale, Amortized Cost, Due in one year or less	$ 2,742
Available for Sale, Amortized Cost, Due after one year through five years	10,370
Available for Sale, Amortized Cost, Due after five years through ten years	20,876
Available for Sale, Amortized Cost, Due after ten years	27,270
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis, Total	61,258
Available for Sale, Amortized Cost, Mortgage-backed securities-government sponsored agencies	131,382
Available for Sale, Amortized Cost, Total	192,640
Available for Sale, Fair Value, Due in one year or less	2,747
Available for Sale, Fair Value, Due after one year through five years	10,377
Available for Sale, Fair Value, Due after five years through ten years	21,091
Available for Sale, Fair Value, Due after ten years	28,371
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Total	62,586
Available for Sale, Fair Value, Mortgage-backed securities-government sponsored agencies	134,412
Available for Sale, Fair Value, Total	$ 196,998

Securities (Gross Realized Gain

Securities (Gross Realized Gains and Losses on Sales of Securities Available-for-Sale) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Securities [Abstract]
Gross realized gains	$ 38	$ 0
Gross realized losses	0	0
Net realized gain	38	0
Proceeds from sale of securities	$ 8,224	$ 327

Loans Receivable and Allowanc_3

Loans Receivable and Allowance for Loan Losses (Narrative) (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)propertyloan	Dec. 31, 2019USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real Estate Acquired Through Foreclosure	$ 1,077,000	$ 1,556,000
Loans and Leases Receivable, Gross	928,597,000	$ 924,676,000
Allowance for Loan and Lease Losses, Adjustments, Other	(1,087,000)
Allowance for Loan and Lease Losses, Period Increase (Decrease)	$ 1,742,000
Loan growth	1.72%	8.75%
Outstanding Balance	$ 777,000	$ 793,000
Multiple Properties [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real Estate Acquired Through Foreclosure	$ 479,000
Number Of Properties Disposed By Sale | property	1
Commercial Rentals [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans and Leases Receivable, Gross	$ 88,800,000
Commercial Rentals [Member] | Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration Risk, Percentage	9.60%
Hospitality Lodging Industry [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans and Leases Receivable, Gross	$ 65,300,000
Hospitality Lodging Industry [Member] | Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration Risk, Percentage	7.10%
Property [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivables, Impaired, Troubled Debt Restructuring, Write-down	$ 33,000
Residential Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number Of Properties Under Foreclosure Proceedings | property	3
Mortgage Loans in Process of Foreclosure, Amount	$ 296,000
Loans and Leases Receivable, Gross	227,373,000	229,781,000
Commercial Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans and Leases Receivable, Gross	398,492,000	391,327,000
Troubled Debt Restructured Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Impaired Financing Receivable, Related Allowance	$ 0	0
New Loans Identified as Troubled Debt Restructurings, Number of Loans | loan	0
Financing Receivable, Troubled Debt Restructuring	$ 96,000	$ 99,000
Delaware Bancshares, Inc. Acquisition [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Assets, Fair Value Adjustment	499,000
Outstanding Balance	1,397,000
Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Annual Loan Review threshold, amount	$ 1,500,000

Loans Receivable and Allowanc_4

Loans Receivable and Allowance for Loan Losses (Composition of the Loan Portfolio) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 928,597	$ 924,676
Deferred fees, net	(32)	(95)
Total loans receivable	928,565	924,581
Allowance for loan losses	(9,088)	(8,509)	$ (8,349)	$ (8,452)
Net loans receivable	$ 919,477	$ 916,072
Percent of Loans	100.00%	100.00%
Residential Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 227,373	$ 229,781
Allowance for loan losses	$ (1,644)	$ (1,552)	(1,455)	(1,328)
Percent of Loans	24.50%	24.90%
Commercial Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 398,492	$ 391,327
Allowance for loan losses	$ (4,915)	$ (4,687)	(4,947)	(5,455)
Percent of Loans	42.90%	42.30%
Construction Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 16,622	$ 17,732
Allowance for loan losses	$ (87)	$ (95)	(108)	(93)
Percent of Loans	1.80%	1.90%
Commercial [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 132,716	$ 134,150
Allowance for loan losses	$ (1,064)	$ (949)	(811)	(712)
Percent of Loans	14.30%	14.50%
Consumer Loans To Individuals [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 153,394	$ 151,686
Allowance for loan losses	$ (1,378)	$ (1,226)	$ (1,028)	$ (864)
Percent of Loans	16.50%	16.40%

Loans Receivable and Allowanc_5

Loans Receivable and Allowance for Loan Losses (Information Regarding Loans Acquired and Accounted for in Accordance with ASC 310-30) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Loans Receivable and Allowance for Loan Losses [Abstract]
Outstanding Balance	$ 777	$ 793
Carrying Amount	$ 680	$ 696

Loans Receivable and Allowanc_6

Loans Receivable and Allowance for Loan Losses (Summary of Amount of Loans in Each Category that were Individually and Collectively Evaluated for Impairment) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Individually evaluated for impairment	$ 2,096	$ 2,144
Loans acquired with deteriorated credit quality	680	696
Collectively evaluated for impairment	925,821	921,836
Total Loans	928,597	924,676
Residential Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Individually evaluated for impairment	0	0
Loans acquired with deteriorated credit quality	467	476
Collectively evaluated for impairment	226,906	229,305
Total Loans	227,373	229,781
Commercial Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Individually evaluated for impairment	2,096	2,144
Loans acquired with deteriorated credit quality	213	220
Collectively evaluated for impairment	396,183	388,963
Total Loans	398,492	391,327
Construction Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Individually evaluated for impairment	0	0
Loans acquired with deteriorated credit quality	0	0
Collectively evaluated for impairment	16,622	17,732
Total Loans	16,622	17,732
Commercial [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Individually evaluated for impairment	0	0
Loans acquired with deteriorated credit quality	0	0
Collectively evaluated for impairment	132,716	134,150
Total Loans	132,716	134,150
Consumer Loans To Individuals [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Individually evaluated for impairment	0	0
Loans acquired with deteriorated credit quality	0	0
Collectively evaluated for impairment	153,394	151,686
Total Loans	$ 153,394	$ 151,686

Loans Receivable and Allowanc_7

Loans Receivable and Allowance for Loan Losses (Impaired Loans and Related Interest Income by Loan Portfolio Class) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Financing Receivable, Impaired [Line Items]
Average Recorded Investment, Total	$ 2,098	$ 885
Interest Income Recognized, Total	3	0
Impaired Loans [Member]
Financing Receivable, Impaired [Line Items]
Impaired Financing Receivable, with No Related Allowance, Recorded Investment	173		$ 143
Impaired Financing Receivable, with Related Allowance, Recorded Investment	1,923		2,001
Impaired Financing Receivable, Recorded Investment	2,096		2,144
Unpaid Principal Balance, With no related allowance recorded	173		394
Unpaid Principal Balance, With an allowance recorded	1,923		2,001
Unpaid Principal Balance, Total	2,096		2,395
Associated Allowance	392		417
Commercial Real Estate Loans [Member]
Financing Receivable, Impaired [Line Items]
Average Recorded Investment, Total	2,098	885
Interest Income Recognized, Total	3	$ 0
Commercial Real Estate Loans [Member] | Impaired Loans [Member]
Financing Receivable, Impaired [Line Items]
Impaired Financing Receivable, with No Related Allowance, Recorded Investment	173		143
Impaired Financing Receivable, with Related Allowance, Recorded Investment	1,923		2,001
Impaired Financing Receivable, Recorded Investment	2,096		2,144
Unpaid Principal Balance, With no related allowance recorded	173		394
Unpaid Principal Balance, With an allowance recorded	1,923		2,001
Unpaid Principal Balance, Total	2,096		2,395
Associated Allowance	$ 392		$ 417

Loans Receivable and Allowanc_8

Loans Receivable and Allowance for Loan Losses (Classes of the Loan Portfolio Summarized by the Aggregate Risk Rating) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	$ 397,389	$ 399,199
Total Summarized by Aggregate Risk Rating [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	531,208	525,477
Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	517,196	509,804
Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	10,873	12,516
Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	3,139	3,157
Doubtful Or Loss [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	0	0
Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	396,742	398,553
Nonperforming [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	647	646
Commercial Real Estate Loans [Member] | Total Summarized by Aggregate Risk Rating [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	398,492	391,327
Commercial Real Estate Loans [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	384,948	376,109
Commercial Real Estate Loans [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	10,633	12,268
Commercial Real Estate Loans [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	2,911	2,950
Commercial Real Estate Loans [Member] | Doubtful Or Loss [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	0	0
Commercial [Member] | Total Summarized by Aggregate Risk Rating [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	132,716	134,150
Commercial [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	132,248	133,695
Commercial [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	240	248
Commercial [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	228	207
Commercial [Member] | Doubtful Or Loss [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	0	0
Residential Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	227,373	229,781
Residential Real Estate Loans [Member] | Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	226,894	229,214
Residential Real Estate Loans [Member] | Nonperforming [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	479	567
Construction Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	16,622	17,732
Construction Real Estate Loans [Member] | Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	16,622	17,732
Construction Real Estate Loans [Member] | Nonperforming [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	0	0
Consumer Loans To Individuals [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	153,394	151,686
Consumer Loans To Individuals [Member] | Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	153,226	151,607
Consumer Loans To Individuals [Member] | Nonperforming [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Amount	$ 168	$ 79

Loans Receivable and Allowanc_9

Loans Receivable and Allowance for Loan Losses (Loan Portfolio Summarized by the Past Due Status) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Current	$ 923,371	$ 919,381
Non-Accrual	2,743	795
Total Past Due and Non-Accrual	5,226	5,295
Total Loans	928,597	924,676
Financing Receivables, 31 to 60 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	1,975	1,218
Financing Receivables, 61 to 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	508	3,282
Financing Receivables, Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	0
Residential Real Estate Loans [Member]
Financing Receivable, Past Due [Line Items]
Current	225,840	228,242
Non-Accrual	479	567
Total Past Due and Non-Accrual	1,533	1,539
Total Loans	227,373	229,781
Residential Real Estate Loans [Member] | Financing Receivables, 31 to 60 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	849	727
Residential Real Estate Loans [Member] | Financing Receivables, 61 to 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	205	245
Residential Real Estate Loans [Member] | Financing Receivables, Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	0
Commercial Real Estate Loans [Member]
Financing Receivable, Past Due [Line Items]
Current	395,516	388,117
Non-Accrual	2,043	99
Total Past Due and Non-Accrual	2,976	3,210
Total Loans	398,492	391,327
Commercial Real Estate Loans [Member] | Financing Receivables, 31 to 60 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	784	176
Commercial Real Estate Loans [Member] | Financing Receivables, 61 to 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	149	2,935
Commercial Real Estate Loans [Member] | Financing Receivables, Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	0
Construction Real Estate Loans [Member]
Financing Receivable, Past Due [Line Items]
Current	16,622	17,695
Non-Accrual	0	0
Total Past Due and Non-Accrual	0	37
Total Loans	16,622	17,732
Construction Real Estate Loans [Member] | Financing Receivables, 31 to 60 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	0
Construction Real Estate Loans [Member] | Financing Receivables, 61 to 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	37
Construction Real Estate Loans [Member] | Financing Receivables, Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	0
Commercial [Member]
Financing Receivable, Past Due [Line Items]
Current	132,623	134,018
Non-Accrual	53	50
Total Past Due and Non-Accrual	93	132
Total Loans	132,716	134,150
Commercial [Member] | Financing Receivables, 31 to 60 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	82
Commercial [Member] | Financing Receivables, 61 to 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	40	0
Commercial [Member] | Financing Receivables, Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	0	0
Consumer Loans To Individuals [Member]
Financing Receivable, Past Due [Line Items]
Current	152,770	151,309
Non-Accrual	168	79
Total Past Due and Non-Accrual	624	377
Total Loans	153,394	151,686
Consumer Loans To Individuals [Member] | Financing Receivables, 31 to 60 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	342	233
Consumer Loans To Individuals [Member] | Financing Receivables, 61 to 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	114	65
Consumer Loans To Individuals [Member] | Financing Receivables, Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Past Due	$ 0	$ 0

Loans Receivable and Allowan_10

Loans Receivable and Allowance for Loan Losses (Allowance for Loan Losses and Recorded Investment in Financing Receivables) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Financing Receivable, Allowance for Credit Loss [Line Items]
Beginning balance,	$ 8,509	$ 8,452
Charge Offs	(150)	(598)
Recoveries	29	45
Provision for loan losses	700	450
Ending balance,	9,088	8,349
Ending balance individually evaluated for impairment	392	0
Ending balance collectively evaluated for impairment	8,696	8,349
Residential Real Estate Loans [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Beginning balance,	1,552	1,328
Charge Offs	(1)	(65)
Recoveries	2	11
Provision for loan losses	91	181
Ending balance,	1,644	1,455
Ending balance individually evaluated for impairment	0	0
Ending balance collectively evaluated for impairment	1,644	1,455
Commercial Real Estate Loans [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Beginning balance,	4,687	5,455
Charge Offs	(33)	(469)
Recoveries	4	10
Provision for loan losses	257	(49)
Ending balance,	4,915	4,947
Ending balance individually evaluated for impairment	392	0
Ending balance collectively evaluated for impairment	4,523	4,947
Construction Real Estate Loans [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Beginning balance,	95	93
Charge Offs	0	0
Recoveries	0	0
Provision for loan losses	(8)	15
Ending balance,	87	108
Ending balance individually evaluated for impairment	0	0
Ending balance collectively evaluated for impairment	87	108
Commercial [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Beginning balance,	949	712
Charge Offs	0	(1)
Recoveries	10	10
Provision for loan losses	105	90
Ending balance,	1,064	811
Ending balance individually evaluated for impairment	0	0
Ending balance collectively evaluated for impairment	1,064	811
Consumer Loans To Individuals [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Beginning balance,	1,226	864
Charge Offs	(116)	(63)
Recoveries	13	14
Provision for loan losses	255	213
Ending balance,	1,378	1,028
Ending balance individually evaluated for impairment	0	0
Ending balance collectively evaluated for impairment	$ 1,378	$ 1,028

Operating Leases (Narrative) (D

Operating Leases (Narrative) (Details)	3 Months Ended
	Mar. 31, 2020USD ($)item	Mar. 31, 2019USD ($)
Operating Leases [Abstract]
Number of operating leases | item	7
Lease, Cost | $	$ 140,000	$ 128,000

Operating Leases (Lease Cost) (

Operating Leases (Lease Cost) (Details)	Dec. 31, 2019
Operating Leases [Abstract]
Weighted-average remaining term	12 years 10 months 24 days
Weighted-average discount rate	3.21%

Operating Leases (Undiscounted

Operating Leases (Undiscounted Cash Flows Due) (Details) $ in Thousands	Mar. 31, 2020USD ($)
Operating Leases [Abstract]
2020	$ 401
2021	535
2022	535
2023	535
2024	544
2025 and thereafter	3,879
Total undiscounted cash flows	6,429
Discount on cash flows	(1,204)
Total lease liabilities	$ 5,225

Fair Value of Assets and Liab_3

Fair Value of Assets and Liabilities (Narrative) (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)loan	Dec. 31, 2019USD ($)loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of impaired loans not requiring a valuation allowance | loan		2
Impaired Loans, Cumulative Charge-Offs	$ 33
Number of impaired loans requiring a valuation allowance | loan	1
Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 1,531	$ 1,584
Valuation allowance	$ 392	$ 417

Fair Value of Assets and Liab_4

Fair Value of Assets and Liabilities (Fair Value, Assets Measured on Recurring Basis) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 196,998	$ 210,205
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	196,998	210,205
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	196,998	210,205
Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
States And Political Subdivisions [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	59,521	71,305
States And Political Subdivisions [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	59,521	71,305
States And Political Subdivisions [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
States And Political Subdivisions [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	59,521	71,305
States And Political Subdivisions [Member] | Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Corporate Obligations [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,065	4,100
Corporate Obligations [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,065	4,100
Corporate Obligations [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Corporate Obligations [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,065	4,100
Corporate Obligations [Member] | Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Mortgage-backed Securities-Government Sponsored Entities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	134,412	134,800
Mortgage-backed Securities-Government Sponsored Entities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	134,412	134,800
Mortgage-backed Securities-Government Sponsored Entities [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Mortgage-backed Securities-Government Sponsored Entities [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	134,412	134,800
Mortgage-backed Securities-Government Sponsored Entities [Member] | Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 0	$ 0

Fair Value of Assets and Liab_5

Fair Value of Assets and Liabilities (Fair Value, Assets and Liabilities Measured on Nonrecurring Basis) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 1,531	$ 1,584
Fair Value, Nonrecurring [Member] | Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	1,531	1,584
Fair Value, Nonrecurring [Member] | Impaired Loans [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Nonrecurring [Member] | Impaired Loans [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Nonrecurring [Member] | Impaired Loans [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	1,531	1,584
Fair Value, Nonrecurring [Member] | Foreclosed Real Estate Owned [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	1,077	1,556
Fair Value, Nonrecurring [Member] | Foreclosed Real Estate Owned [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Nonrecurring [Member] | Foreclosed Real Estate Owned [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Nonrecurring [Member] | Foreclosed Real Estate Owned [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 1,077	$ 1,556

Fair Value of Assets and Liab_6

Fair Value of Assets and Liabilities (Additional Qualitative Information about Level 3 Assets) (Details) $ in Thousands	Mar. 31, 2020USD ($)item	Dec. 31, 2019USD ($)item
Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure | $	$ 1,531	$ 1,584
Impaired Loans [Member] | Appraisal of collateral [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure | $	$ 1,531	1,531
Impaired Loans [Member] | Present value of future cash flows [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure | $		$ 53
Impaired Loans [Member] | Minimum [Member] | Appraisal of collateral [Member] | Measurement Input, Appraised Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing Asset, Measurement Input	0.1	0.1
Impaired Loans [Member] | Minimum [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing Asset, Measurement Input		0.04
Impaired Loans [Member] | Maximum [Member] | Appraisal of collateral [Member] | Measurement Input, Appraised Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing Asset, Measurement Input	0.1	0.1
Impaired Loans [Member] | Maximum [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing Asset, Measurement Input		0.0697
Impaired Loans [Member] | Weighted Average [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing Asset, Measurement Input		5.550
Other Real Estate Owned [Member] | Appraisal of collateral [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure | $	$ 1,077	$ 1,556
Other Real Estate Owned [Member] | Minimum [Member] | Appraisal of collateral [Member] | Measurement Input, Cost to Sell [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Real Estate Owned, Measurement Input	0	0
Other Real Estate Owned [Member] | Maximum [Member] | Appraisal of collateral [Member] | Measurement Input, Cost to Sell [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Real Estate Owned, Measurement Input	0.0700	0.0700
Other Real Estate Owned [Member] | Weighted Average [Member] | Appraisal of collateral [Member] | Measurement Input, Cost to Sell [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Real Estate Owned, Measurement Input	6.2700	4.340

Fair Value of Assets and Liab_7

Fair Value of Assets and Liabilities (Fair Value, by Balance Sheet Grouping) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets: Cash and cash equivalents, Fair Value Disclosure	$ 38,418	$ 15,415
Financial assets: Loans receivable, net, Fair Value Disclosure	969,839	943,143
Financial assets: Mortgage servicing rights, Fair Value Disclosure	226	226
Financial assets: Regulatory stock, Fair Value Disclosure	3,770	4,844
Financial assets: Bank owned life insurance, Fair Value Disclosure	38,971	38,763
Financial assets: Accrued interest receivable, Fair Value Disclosure	3,669	3,719
Financial liabilities: Deposits, Fair Value Disclosure	994,357	961,120
Financial liabilities: Short-term borrowings, Fair Value Disclosure	40,656	62,256
Financial liabilities: Other borrowings, Fair Value Disclosure	52,410	56,618
Financial liabilities: Accrued interest payable, Fair Value Disclosure	2,895	2,432
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure	0	0
Financial assets: Cash and cash equivalents	38,418	15,415	$ 19,874	$ 18,348
Financial assets: Loans receivable, net	919,477	916,072
Financial assets: Mortgage servicing rights	190	187
Financial assets: Regulatory stock	3,770	4,844
Financial assets: Bank owned life insurance	38,971	38,763
Financial assets: Accrued interest receivable	3,669	3,719
Financial liabilities: Deposits	990,160	957,529
Financial liabilities: Short-term borrowings	40,656	62,256
Financial liabilities: Other borrowings	51,350	56,438
Financial liabilities: Accrued interest payable	2,895	2,432
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit	0	0
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets: Cash and cash equivalents, Fair Value Disclosure	38,418	15,415
Financial assets: Loans receivable, net, Fair Value Disclosure	0	0
Financial assets: Mortgage servicing rights, Fair Value Disclosure	0	0
Financial assets: Regulatory stock, Fair Value Disclosure	3,770	4,844
Financial assets: Bank owned life insurance, Fair Value Disclosure	38,971	38,763
Financial assets: Accrued interest receivable, Fair Value Disclosure	3,669	3,719
Financial liabilities: Deposits, Fair Value Disclosure	612,778	596,811
Financial liabilities: Short-term borrowings, Fair Value Disclosure	40,656	62,256
Financial liabilities: Other borrowings, Fair Value Disclosure	0	0
Financial liabilities: Accrued interest payable, Fair Value Disclosure	2,895	2,432
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets: Cash and cash equivalents, Fair Value Disclosure	0	0
Financial assets: Loans receivable, net, Fair Value Disclosure	0	0
Financial assets: Mortgage servicing rights, Fair Value Disclosure	0	0
Financial assets: Regulatory stock, Fair Value Disclosure	0	0
Financial assets: Bank owned life insurance, Fair Value Disclosure	0	0
Financial assets: Accrued interest receivable, Fair Value Disclosure	0	0
Financial liabilities: Deposits, Fair Value Disclosure	0	0
Financial liabilities: Short-term borrowings, Fair Value Disclosure	0	0
Financial liabilities: Other borrowings, Fair Value Disclosure	0	0
Financial liabilities: Accrued interest payable, Fair Value Disclosure	0	0
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure	0	0
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets: Cash and cash equivalents, Fair Value Disclosure	0	0
Financial assets: Loans receivable, net, Fair Value Disclosure	969,839	943,143
Financial assets: Mortgage servicing rights, Fair Value Disclosure	226	226
Financial assets: Regulatory stock, Fair Value Disclosure	0	0
Financial assets: Bank owned life insurance, Fair Value Disclosure	0	0
Financial assets: Accrued interest receivable, Fair Value Disclosure	0	0
Financial liabilities: Deposits, Fair Value Disclosure	381,579	364,309
Financial liabilities: Short-term borrowings, Fair Value Disclosure	0	0
Financial liabilities: Other borrowings, Fair Value Disclosure	52,410	56,618
Financial liabilities: Accrued interest payable, Fair Value Disclosure	0	0
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure	$ 0	$ 0

Proposed Acquisition of UpSta_2

Proposed Acquisition of UpState New York Bancorp, Inc. (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Total Assets	$ 1,242,291	$ 1,230,610
Net loans receivable	919,477	916,072
Deposits	990,160	957,529
Stockholders' equity	$ 142,187	137,428	$ 126,772	$ 122,285
UpState New York Bancorp, Inc. [Member]
Business Acquisition [Line Items]
Total Assets		439,600
Net loans receivable		380,700
Deposits		387,900
Stockholders' equity		$ 46,400
Conversion of shares	0.9390
Cash paid per share	$ 33.33
Percent exchanged for stock	90.00%
Percent exchanged for cash	10.00%
Minimum [Member] | UpState New York Bancorp, Inc. [Member]
Business Acquisition [Line Items]
Business Combination, Threshold For Termination	20.00%
Maximum [Member] | UpState New York Bancorp, Inc. [Member]
Business Acquisition [Line Items]
Performance conditions	$ 0.67

Risks and Uncertainties (Narrat

Risks and Uncertainties (Narrative) (Details) - Subsequent Event [Member] $ in Millions	Apr. 30, 2020USD ($)loan
Risks And Uncertainties [Line Items]
Number of applications | loan	472
PPP loans | $	$ 59.2
CARES Act, Number Of Deferrals | loan	151
CARES Act, Amount Of Mortgage Payment Deferrals | $	$ 10.4
CARES Act, Number Of Requests To Modify Loans | loan	754
CARES Act, Deferred Principal And Interest | $	$ 165.4

Risks and Uncertainties (Summar

Risks and Uncertainties (Summary of Loan Forbearance) (Details) - Subsequent Event [Member] $ in Thousands	Apr. 30, 2020USD ($)loan
Risks And Uncertainties [Line Items]
Number of Loans | loan	754
Balance | $	$ 165,360
Residential Real Estate Loans [Member]
Risks And Uncertainties [Line Items]
Number of Loans | loan	152
Balance | $	$ 10,359
Commercial Real Estate Loans [Member]
Risks And Uncertainties [Line Items]
Number of Loans | loan	167
Balance | $	$ 129,851
Construction Real Estate Loans [Member]
Risks And Uncertainties [Line Items]
Number of Loans | loan	14
Balance | $	$ 5,005
Commercial, Financial And Agricultural [Member]
Risks And Uncertainties [Line Items]
Number of Loans | loan	60
Balance | $	$ 11,797
Consumer Loans To Individuals [Member]
Risks And Uncertainties [Line Items]
Number of Loans | loan	361
Balance | $	$ 8,348